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Women have greater incidence and prevalence of Major Depressive Disorder (MDD) 
than men during the reproductive life phase when ovarian hormones fluctuate, suggesting that 
ovarian hormones have a significant role in MDD etiology in women. As the core symptoms of 
MDD are indicative of alterations in stress responding, emotional processing, and mood 
regulation, examining the effects of the estrogen on these processes in women may provide a 
better understanding of the role of estrogen in the sex difference in MDD rates. The general aim 
of this dissertation was to examine neural, emotional, and attentional processes related to stress 
response alterations and cognitive bias in MDD in women.  
 
To examine menstrual phase and estradiol level effects on the neural and mood response 
to psychosocial stress, healthy, normally cycling women were examined at either the high or low 
estradiol phase of the menstrual cycle. Participants were exposed to the Montreal Imaging Stress 
Task (MIST), with brain activity measured through functional magnetic resonance imaging 
(fMRI), and behavioral response assessed with subjective mood and stress measures. We found 
that women during the high estradiol phase showed significantly less hippocampal deactivation 
during psychosocial stress compared to women during the low estradiol phase. Additionally, 
women with higher estradiol levels also had less subjective distress in response to the MIST than 
women with lower estradiol levels. These results suggest that high estradiol may be protective 
against the shifts in brain system activity and negative mood responses associated with 
psychosocial stress. Periods of low estradiol may enhance the negative impact of psychosocial 
stress on neural activity and mood and thus contribute to MDD risk in vulnerable women. 
 
The relation of cognitive bias to depression history in women was examined in 
postmenopausal women with and without a history of major depression using an emotion dot 
probe task during fMRI. Women with remitted MDD showed greater attentional facilitation for 
negative images than women with no history of MDD that was directly correlated with amygdala 
activity for negative images and amygdala-hippocampal connectivity in a resting scan. These 
findings provide evidence that differences in activity and functional connectivity in emotional 
processing networks may provide a neurobiological basis for continued cognitive bias in remitted 
MDD. Preliminary data indicate that estradiol treatment reduces amygdala-hippocampal 
connectivity specifically in women with a history of MDD and has interactive effects with MDD 
history on the mood response to psychosocial stress following the MIST such that women with a 
history of MDD appear to benefit from estradiol treatment while women without such history do 
not. Women with a history of or vulnerability to MDD may be particularly sensitive to the 
positive effects of estradiol on brain systems important to regulating emotional responses to 
psychosocial stress. The findings presented in this dissertation suggest that estrogen fluctuations 
across the menstrual cycle and at other reproductive events may contribute to depression risk 
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Chapter 1: Comprehensive Literature review 
1.1. Introduction 
 Major depressive disorder (MDD) is a complex disorder that impacts multiple systems in 
the brain and periphery and alters emotional and cognitive processes that are integral to healthy 
daily functioning and quality of life. The incidence and prevalence of MDD in women is 2-3 
times higher than in men (Kessler et al., 2003, 2005). In men new onset rates and 12 month 
prevalence of MDD remain fairly constant from puberty to old age, but increase in women at 
puberty and remain higher than men until menopause (Kessler et al., 2003, 2005a). Depression 
risk for women changes across the lifespan with higher risk corresponding to life stages in which 
ovarian hormones fluctuate across the monthly menstrual cycle or with reproductive events such 
as parturition and the menopause transition (Gonda et al., 2008; Schiller et al., 2015; Schmidt 
and Rubinow, 2010). Ovarian hormones have varied effects in the brain including modulation of 
emotional perception, mood regulation, and stress response, as well as effects on cognition. The 
concurrence of increased depression risk with the reproductive life phase indicates that ovarian 
hormone fluctuations may contribute to mood disruption in women. Naturally occurring periods 
of low estrogen (premenstrually and during late perimenopause) may introduce windows of 
increased vulnerability for depression through the withdrawal of beneficial modulation of 
emotional processing and mood regulation. The research included in this dissertation examined 






1.2. Major Depressive 
 Disorder 
1.2.1 MDD Diagnosis and Epidemiology 
 According to the Diagnostic and Statistical Manual of Mental Disorders 5, MDD is 
defined as experiencing one or more major depressive episodes (lasting at least 2 weeks), that are 
not better explained by another medical condition or other psychiatric disorder (American 
Psychiatric Association, 2013). Major depressive episodes must include at least 5 of 9 symptoms 
within the same 2 week period: depressed/ sad mood, anhedonia, change in appetite, insomnia or 
hypersomnia, psychomotor agitation or retardation, fatigue, negative feelings of self 
(worthlessness, guilt), impaired concentration or decision making, thoughts of death or suicidal 
ideation/attempt. These symptoms must cause significant distress and represent a change from 
previous functioning (American Psychiatric Association, 2013). The twelve month prevalence of 
MDD in the United States is just under 7% (Substance Abuse and Mental Health Services 
Administration, 2013) and is predicted to increase in the future (Brundtland, 2001). MDD is the 
largest contributor to disability due to mental and behavioral disorders (3.7% of US disability-
adjusted life years and 8.3% of US years lived with disability) (Murray et al., 2013). Although 
mood and anxiety disorders are the most prevalent psychiatric disorders in the US, current 
strategies for treating MDD fail to induce lasting remission or prevent recurrence in a significant 
portion of sufferers.  
  Current first-line antidepressant medications are ineffective in inducing remission 
in almost a third of patients (Adli et al., 2006). If patients do not respond to the first 
antidepressant treatment subsequent attempts with other medications are less effective 
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(Oestergaard and Møldrup, 2011). The response rate for the most commonly prescribed anti-
depressants, selective serotonin reuptake inhibitors (SSRIs) is 30% (Trivedi et al., 2006), and 
depressive symptoms often return with SSRI discontinuation (Glue et al., 2010). Because many 
individuals with MDD do not experience successful treatment with standard pharmacological 
approaches, or have returning depressive symptoms after discontinuing antidepressants, 
augmenting current treatments and preventing depression recurrence remains a significant goal 
for treatment strategies. Better understanding the role of ovarian hormones in MDD in women 
may provide novel targets or better focus prevention strategies.  
 
1.2.2 MDD Recurrence 
 MDD is often recurrent, with recurrence rates as high as 85% in 15 years in individuals 
with past MDD episodes either in specialized mental health or primary care for MDD, and up to 
35% in 15 years in the general population (Hardeveld et al., 2010). Most individuals with MDD 
have more than one depressive episode, with the response to antidepressant treatments 
decreasing with subsequent episodes (Lee et al., 2012). While there are a number of risk factors 
that contribute to first onset depression, the primary predictors of recurrence are the number of 
previous episodes and residual depressive symptoms that remain during remission (Hardeveld et 
al., 2010). The “kindling” hypotheses of depression recurrence suggests that with successive 
depressive episodes the threshold for response to stressful life events or depression triggers is 
lowered and vulnerability for future depressive episodes increases (Monroe and Harkness, 2005). 
Depressive symptoms during remission may indicate trait vulnerability factors that predispose 
emotional or cognitive processes towards depressive responding. 
4 
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 Hammen and colleagues have proposed a “stress generation” hypothesis of depression 
recurrence; individuals who experience recurrent depression are more likely than people with no 
medical illness to experience subsequent stressful events (Hammen, 1991), particularly 
“dependent” stressful events, meaning generally interpersonal conflict to which the depressed 
individual contributes. According to this stress generation hypothesis, recurrence results from a 
cycle of psychosocial stress and depression in which stress both contributes to and is a 
consequence of depressive episodes (Hammen, 1991). Depressive episodes may leave a “scar”, 
such as cognitive bias for negative information which results in maladaptive behavior and 
dependent stressful events (Raedt and Koster, 2010). Thus, with each depressive episode the 
association between negative cognitive patterns and negative mood may be reinforced and make 
the individual more vulnerable to future depressive episodes (Dent and Teasdale, 1988).  
 
1.3 Cognitive Models of MDD 
1.3.1 Ventral and Dorsal Systems of Emotion Perception and Regulation 
 Theories of the neurobiology of MDD have evolved into complex network models that 
include cognitive and emotion regulation mechanisms. One useful model that incorporates 
emotion processing and cognitive function is the division of stimuli evaluation and emotion 
regulation into ventral and dorsal brain systems (Figure 1) (Phillips et al., 2008). Structures in the 
ventral system include the amygdala and ventral and orbital prefrontal areas (Drevets et al., 
2008; Mayberg, 1997; Phillips et al., 2008). The dorsal division includes the hippocampus, 
dorsal anterior cingulate cortex (dACC), subgenual prefrontal cortex (subgenual PFC) and dorsal 
lateral prefrontal cortex (dlPFC) (Drevets et al., 2008; Mayberg, 1997; Phillips et al., 2008). The 
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ventral system allows for the rapid appraisal of emotionally valenced stimuli, while the dorsal 
system provides the capacity to modulate the affective, physiological, and cognitive 
consequences of ventral output (Phillips et al., 2003).  
 
The overlap in circuits for mood regulation and cognitive function in the ventral-dorsal 
model is indicative of an intimate connection between cognition and mood (Fink et al., 1995). 
Becks’ cognitive model of depression posits that individuals with MDD experience information 
according to mood congruent schemas, and are apt to interpret information as reflecting a 
negative self-image, a negative view of external information, and pessimism about the future 
(Beck and Haigh, 2014). This predisposition for experiencing and interpreting information such 
that negative schemas are reinforced may reflect dysregulated ventral-dorsal interactions in 
MDD. Cognitive bias is the predisposition to attend to or remember certain types of information 
over others. The cognitive model of MDD posits that emotional processing circuits in the brain 
Figure 1: Ventral and dorsal brain systems for emotional appraisal and regulation.  
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are altered in depression such that there is a bias toward negative information, and attenuated 
processing of positive information (Disner et al., 2011).  
 
1.3.2 Attention Bias 
Attention is the process by which cognitive resources are allocated to processing 
information and selecting which information is blocked from further processing (Chun and Turk-
Browne, 2007). The focus of attention is determined by interactions between bottom-up 
(stimulus-driven) processes in the ventral system and top-down processes in the dorsal system 
(Egeth and Yantis, 1997). The interplay between attention and memory is complex and the 
pathways and mechanisms involved are not well understood (Chun and Turk-Browne, 2007). 
Because memory capacity is limited, attention has a significant role in determining what 
information is encoded into memory (Chun and Turk-Browne, 2007). Selective attention, the 
process of choosing which stimuli receive attention and which are ignored, is crucial when there 
are competing stimuli present (Chun and Turk-Browne, 2007). Memory deficits and bias for 
negative information have commonly been found in MDD (Sears et al., 2011; Sheline, 2000). It 
may be that altered memory in MDD is largely due to the effects of attention bias on sensory 
processing of emotional information and subsequent effects on memory encoding (Raedt and 
Koster, 2010). Emotionally-valenced stimuli drive bottom-up attention more than emotionally 
neutral stimuli (Holtmann et al., 2013; McHugo et al., 2013; Peers et al., 2013; Stollstorff et al., 
2013). Vuilleumier and colleagues propose a model of attention by which emotional information 
is “amplified” and preferentially processed. In this model the amygdala has a significant role in 
generating “emotional bias signals”; ventral system processes initiated by the amygdala direct 
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attention to emotionally-relevant stimuli and modulate sensory systems such that the processing 
of such stimuli is enhanced and maintained (Pourtois et al., 2013). 
Ventral and dorsal mechanisms interact to guide attention; the ventral system facilitates 
the evaluation of stimuli and directs top-down processes towards emotionally-relevant 
information (Chun and Turk-Browne, 2007), while dorsal system processes maintain attention 
congruent to endogenous goals and motivational states (Mohanty and Sussman, 2013). Conflict 
in top-up and bottom-down attentional processes occur when ventral system evaluation of stimuli 
and subsequent emotional responses do not accord with the motivations and goals impacting 
dorsal-system activity (Chun and Turk-Browne, 2007; Okon-Singer et al., 2015). Dorsal system 
regulation of attention is influenced by endogenous motivational and emotional states. 
Depending on these states the dorsal system may respond to attentional conflict by counteracting 
amygdala-driven activity and reducing attention to and sensory processing of emotional stimuli, 
directing attention to competing stimuli, or directing top-down attention to the stimuli driving 
bottom-up attention (Pourtois et al., 2013). Studies demonstrating that acute stress and anxiety 
enhances both amygdala response and subsequent sensory systems activity to negative emotional 
stimuli (Bishop et al., 2004; Cornwell et al., 2011; van Marle et al., 2009; Shackman et al., 2011; 
Vogel and Luck, 2000) provide evidence that negative mood states bias attention and sensory 







1.3.3 Cognitive Bias in Depression 
 Mood congruent cognitive bias is a common finding in currently depressed individuals 
(Gaddy and Ingram, 2014). A recent meta-analysis of eye tracking in attention tasks found that 
individuals with current MDD show blunted orienting responses and reduced maintenance of 
attention to pleasant stimuli but maintain attention for negatively valenced stimuli (Armstrong 
and Olatunji, 2013). Negative cognitive bias not only affects processing of emotional 
information but appears to be related to emotional responding to psychosocial stress. Individuals 
with current MDD fixate longer and more frequently on sad faces than healthy controls, and also 
take longer to recover from to negative mood following a laboratory stressor (Sanchez et al., 
2013). Negative cognitive bias in current MDD may result from mood-congruent cognitive 
processing during depressive episodes; negative information is processed more readily because it 
accords with internal emotional processes during depressive episodes. However, according to 
Beck’s cognitive model of depression (Beck and Haigh, 2014; Beck, 2005), cognitive bias for 
negative information remains during remission and presents a trait vulnerability for depression 
rather than a consequence of negative mood. A causative link between cognitive bias and mood 
is also suggested by the finding that experimental methods that modulate attention bias also 
affect anxiety and depression symptoms. Cognitive bias modification (CBM) is an experimental 
technique in which attention is trained away from or towards negative stimuli and has been 
found to be effective in modulating depressive symptoms as well as attentional performance 
(Hallion and Ruscio, 2011). The mood effects of CBM training demonstrate that cognitive bias 




 Cognitive models of MDD accord with neural system dysregulation models in that 
cognitive bias is associated with altered activity in dorsal and ventral systems (Raedt and Koster, 
2010). Greater activity in ventral system structures and less activity in dorsal structures to 
negative stimuli is a consistent finding in MDD (Drevets et al., 2008; Savitz and Drevets, 2009). 
Enhanced amygdala activity in currently depressed and at risk individuals (Arnone et al., 2012; 
Zhong et al., 2012) may indicate greater signal driven automatic evaluation or reduced regulation 
by dorsal system structures resulting in biased processing of negative information (Sears et al., 
2011). Neuroimaging studies show that in MDD additional regions of the prefrontal cortex are 
recruited during automatic control of emotional responses, suggesting that compensatory activity 
in dorsal regions may be activated to control enhanced bottom-up activity, driven by amygdala 
hyperactivity in MDD (Drevets, 2003; Drevets et al., 2002; Zhong et al., 2012).  
Individuals with MDD appear to have diminished dorsal system capacity to regulate 
ventral-driven sensory and emotional processing of negatively valenced information. 
Establishing dorsal system regulation of emotional processing may be an important component 
of successful MDD remission (Erk et al., 2010; Gotlib and Joormann, 2010). However, even 
during remission, automatic ventral system processes may be prioritized when cognitive 
resources need to be allocated efficiently (such as during stress) resulting in negative mood and 
reinforcing negative cognitive bias. Cognitive bias in remitted MDD may reflect continued 
dysregulation in emotional processes and a neurobiological basis for vulnerability to MDD 





1.4 Stress and Major Depression 
1.4.1 The Stress Response System 
 Stressors are perceived or actual threats to homeostasis that may be physical or 
psychosocial and the healthy stress response is a coordinated neuroendocrine reaction that 
maintains or restores homeostasis (Gold, 2015). The system that is involved in the response to 
stress includes the autonomic nervous system, the hypothalamic pituitary adrenal (HPA) axis, 
and the brain regions that orchestrate the autonomic, hormonal, and emotional response to stress 
(Chrousos and Gold, 1992; Johnson et al., 1992; Sternberg et al., 1992). This system normally 
serves to coordinate optimal neuroendocrine, immune, and autonomic responses to stress (for 
review see Stokes, 1995). During stress, the peptides cortisol releasing factor and arginine 
vasopressin are secreted from the hypothalamus and induce the release of adrenocorticotropic 
hormone from the anterior pituitary. In response to adrenocorticotropic hormone, glucocorticoids 
are released from the cortex of the adrenal glands. In humans the primary glucocorticoid is 
cortisol. Cortisol acts throughout the body to increase the energy available to manage the 
demands of the stressor and maintain homeostasis. The endocrine response to stress is regulated 
through negative feedback mechanisms of glucocorticoids at the pituitary, hypothalamus, 




   
   The optimal HPA axis response to stress is dynamic, both quickly releasing cortisol and 
quickly stopping the action of cortisol. An efficient HPA response prevents peripheral and 
central nervous system damage due to prolonged cortisol exposure (Lupien et al., 2005). 
Inefficient regulation of the HPA axis and chronic high cortisol exposure is associated with 
increased blood pressure, increased risk for diabetes, hypertension, arterial diseases, impaired 
growth and tissue repair, and suppressed immune function (Derijk and Sternberg, 1994; Lupien 
et al., 2009; Moulton et al., 2015; Munck and Guyre, 1991). Thus, HPA dysregulation is a 




common factor in co-morbid diseases such as depression and cardiovascular disease(Carney and 
Freedland, 2003; Chen et al., 2007; Jiang et al., 2002; Joynt et al., 2003; Miller et al., 2002; 
Nikkheslat et al., 2015). Chronic cortisol dysregulation may negatively impact a variety of body 
systems and may present a general vulnerability factor that contributes to the risk for a number of 
diseases including MDD.  
 
1.4.2 Ventral and Dorsal Systems in the Stress Response 
 The hypothesis that stress system dysfunction is integral to the etiology of MDD is 
consistent with neuroanatomical models of MDD that posit mood dysregulation as a result of an 
imbalance in functional activity in the ventral and dorsal systems, which are sensitive to cortisol 
and show reciprocal activity changes during stress responding (Drevets et al., 2008; Mayberg, 
1997; Phillips et al., 2008).  
During the healthy stress response activity in the brain shifts from dorsal system mood 
regulation to ventral system threat evaluation and management as cognitive resources are 
preferentially allocated to automatic processes for responding to threat (Arnsten, 2009). 
Enhanced ventral activity results in acute dysphoria which is a normal and necessary component 
of the stress response as negative mood motivates managing stressors (Gold, 2015). There are 
two regulatory components of the dorsal system; hippocampal activity is automatically enhanced 
in response to amygdala activity while frontal activity is recruited through later stage or 
voluntary processes (Phillips et al., 2008). In the unstressed state the subgenual PFC inhibits 
amygdala activity and consequently attenuates amygdala-driven attention (Gold, 2015). During 
stress dorsal system function is down-regulated in favor of automatic, rapid emotional responses 
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in the ventral system. Once dorsal activity is decreased through automatic or voluntary 
processes, the amygdala is released from inhibition (Drevets et al., 1997; Simpson et al., 2001). 
The amygdala has a central role in both the mood and cognitive response to stress, 
through reciprocal projections with dorsal system structures, and in orchestrating endocrine and 
autonomic responses through projections to the hypothalamus and central autonomic centers 
(Gold, 2015). The release of amygdala inhibition promotes negative mood and cognitive 
response to stress and both directly and indirectly (through down-regulation of dorsal region 
activity) drives HPA axis and autonomic responses. In a recent expert review Gold posits that an 
unregulated feed-forward system decreased dorsal system activity and increased amygdala 
activation causes a prolonged dysphoric state and biases cognitive processes towards negative 
emotionally valenced information (Gold, 2015). 
 
1.4.3 Stress and Cognition 
The changes in ventral and dorsal activity that occur during that normal stress response 
result in altered cognitive processing of emotional information including memory (McGaugh, 
2004) and attention bias for threatening or negatively valenced stimuli (Arnsten, 2009). 
Normally short-term cognitive bias towards negative information serves to efficiently process 
and manage stressors, however in a dysregulated stress system persistent cognitive bias may 
become established and contribute to cognitive vulnerability for depression. 
 The organization of the stress system in the brain allows for cognitive alterations in 
response to acute cortisol changes. There are two types of receptors for glucocorticoids, 
mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs) (Reul and de Kloet, 
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1985). MRs are expressed exclusively in limbic regions and have much higher affinity for 
glucocorticoids (6-10 times) than GRs which are expressed throughout the brain with high 
density in frontal regions (Fuxe et al., 1985; Patel et al., 2000; Reul and de Kloet, 1985). Because 
of the difference in affinity, MRs are occupied at low glucocorticoid levels while GRs only 
become significantly occupied at high glucocorticoid levels. This dynamic ratio of activation 
between receptors allows for the effects of acute stress to be mediated mainly through GRs 
(Lupien et al., 2005). Basal and acutely elevated glucocorticoid levels have different effects on 
brain function via action at MRs or GRs respectively.  
In human and rodent studies acute glucocorticoids appear to have a biphasic effect on 
cognition with both significantly decreased and increased glucocorticoids impairing memory. 
Low to moderate GR activity may benefit memory and cognitive performance while high GR 
activity under acute stress has detrimental effects on those domains (Lupien et al., 2002; 
Newcomer et al., 1994, 1998, 1999; de Quervain et al., 2000). In both young and older adults 
hippocampal function is impaired under high endogenous cortisol paralleling reduced long term 
potentiation related to high GR occupation in animal models (Lupien et al., 2005, 2009). These 
findings in healthy adults, as well as memory impairment, and hippocampal volume loss in 
patients with Cushing’s disease or on cortisol treatments support the “Glucocorticoid cascade 
hypothesis” which posits a direct effect of chronic high cortisol on hippocampal integrity 
(impaired function and decreased volume) (Sapolsky et al., 1986).  
The hippocampus is an important negative feedback site for cortisol and regulator of 
HPA axis activity (Herman and Cullinan, 1997; Jankord and Herman, 2008). Glucocorticoid 
receptors occupation results in increased hippocampal activity and inhibits HPA axis function; 
however this regulatory loop is suppressed during acute stress to maintain the endocrine response 
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(Feldman and Weidenfeld, 1999). Mild acute stress promotes neurogenesis in the dentate gyrus 
of the hippocampus and appears to support adaptive responding to stress and the efficient return 
to basal HPA axis activity and cortisol levels (Duman and Li, 2012; Ming and Song, 2011). 
Blocking hippocampal neurogenesis during acute stress in mice produces depression-like 
behavior (Snyder et al., 2011), suggesting that hippocampal adaptation may be an integral 
component of the healthy stress response that prevents depressive responding. Additionally, 
animal studies suggest a beneficial effect of acute glucocorticoids on hippocampal function, 
removing corticosterone impairs hippocampally-mediated memory, and replacing corticosterone 
rescues performance (Lupien et al., 2005). However, under chronic stress in rodent models 
hippocampal volume and plasticity is reduced (Magariños and McEwen, 1995; Watanabe et al., 
1992), suggesting that chronically elevated glucocorticoids negatively impact the hippocampus. 
These alterations in hippocampal structure and function may result in stress system dysregulation 
as hippocampal regulation of the HPA axis is reduced. Reduced ability of the hippocampus to 
regulate stress responding and modify its activity in response to acute stress may result in stress 
system dysregulation. 
Prolonged HPA dysregulation may alter the dynamics of MR/ GR activity and modify 
the cognitive effects of acute stress. Chronic high cortisol is reduces MR expression in animal 
studies and thus results in high GR activation (Herman et al., 1995; Kitraki et al., 1999; Sapolsky 
et al., 1986). Lupien’s longitudinal studies in older adults provide evidence that chronically high 
cortisol similarly alters the cognitive effects of stress in humans. Older adults with normal, 
moderate basal cortisol show a beneficial effect of acute cortisol increase on memory, however 
in older adults with high basal cortisol, acutely increased cortisol impairs memory performance, 
suggesting that chronic high cortisol reduces the effect of acute cortisol changes in humans 
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(Lupien et al., 2005). As MR expression decreases under prolonged HPA dysregulation and GRs 
become occupied at lower cortisol levels the cognitive impact of acute stress and chronic high 
cortisol may become more pronounced (Lupien et al., 2005).  
 The acute stress response in the brain is characterized by a shift towards ventral system 
activity and away from dorsal system activity. This shift results in dysphoric mood which 
motivates behavioral responses to stress and cognitive bias in attention and memory that focus 
cognitive resources on managing the stressor. In healthy systems these responses only last as 
long as necessary to cope with the stressor. However, dysregulation of the stress response may 
result in prolonged dysphoric state and a cognitive bias for negative information followed by 
depression. Cognitive and stress-exposure models of MDD are complimentary as altered 
cognitive processing of negative emotional information may result from and be maintained by 
stress system dysregulation. 
 
1.4.4 Stress Dysregulation in MDD 
Altered HPA axis function is common in MDD (Burke et al., 2005; Lupien et al., 2009) 
and the onset of depressive episodes is often attributed to stressful life events (Frank et al., 1994; 
Kendler et al., 2000, 1999). The association of stress with MDD supports a stress-exposure 
model of MDD in which depressive episodes are triggered by stressful events and maladaptive 
responding (Hankin et al., 2007; Liu and Alloy, 2010). Individuals with MDD show chronically 
elevated cortisol, however, cortisol feedback at the pituitary appears to be intact indicating that 
HPA axis dysregulation originates from blunted feedback at the hypothalamus or in higher level 
brain systems that regulate HPA axis activity (Holsboer et al., 1984). Evidence that frontal dorsal 
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system regions may be less sensitive to HPA axis negative feedback in depression is provided by 
reduced cortisol releasing hormone receptor densities in frontal regions in post mortem studies 
following suicide (Nemeroff et al., 1988) indicating that. Cortisol releasing hormone levels are 
elevated in depressed patients and decrease with successful treatment (Nemeroff et al., 1985; 
Widerlöv et al., 1988) again suggesting that MDD is characterized by HPA axis dysregulation 
and remission is associated with restored regulation. Chronically altered sensitivity for cortisol 
releasing hormone and cortisol may have long-term effects on brain regions that respond to these 
hormones.  
The alterations in brain structure and function that are found under chronic stress 
parallel changes in MDD; patients with MDD show structural changes in brain regions that are 
integral to stress responding including decreased subgenual PFC and hippocampal volume and 
increased amygdala volume (McKinnon et al., 2009). Dorsal system volume reductions are likely 
due to the loss of neuronal and glial cells and diminished dendritic arborization (Drevets et al., 
1997, 2008; Jaako-Movits et al., 2006), while in the amygdala dendritic arborization and spine 
density are increased (Drevets, 2003; Price and Drevets, 2012). These changes suggest that 
plasticity is reduced in dorsal regions and increased in amygdala which accords with disrupted 
dorsal system-amygdala interactions as a mechanism in MDD etiology (Gold, 2015).  
 Cognitive alterations in MDD also parallel shifts in cognitive resource allocation during 
stress responding (Gotlib et al., 2004; Isaac et al., 2014; Suslow et al., 2001), indicating that 
dysregulated stress system function may contribute to behavioral changes in MDD. In addition to 
the effects of amygdala hyperactivity, altered HPA axis function and reduced negative feedback 
by glucocorticoids may contribute to hippocampal atrophy seen in MDD. MDD is associated 
with bilateral hippocampal atrophy (8-19%) that appears to have functional significance, as 
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individuals with past MDD (currently in remission) continue to show deficits in hippocampally-
mediated tasks (declarative and verbal memory) (Sheline, 2000). The origin of HPA axis 
dysregulation in MDD remains unknown; however the organization of peripheral and brain stress 
systems make these systems vulnerable to dysregulation (Gold, 2015). MDD may result from an 
initial alteration in stress system function (perhaps through genetic traits or environmental 
factors) that is maintained and amplified through the numerous feedback loops and reciprocal 
interactions that constitute the stress system.  
 In a recent expert review, Gold defines MDD as a disease that contributes to “multiple 
system pathologies” (Gold, 2015). The organization of the stress system with multiple feed 
forward loops to assure successful management of stressors and the mood and cognitive effects 
of even acute, well-managed, stress create a system that is vulnerable to dysregulation when 
confronted with genetic vulnerability or extreme life stressors. The symptoms that characterize 
MDD resemble prolonged unregulated stress responses; once the stress system becomes 
dysregulated, feed-forward mechanisms sustain hypercortisolism and enhanced amygdala 
function, reinforcing the mood and cognitive consequences of stress system activity (Gold, 
2015). Successful MDD treatment likely requires approaches that target multiple mechanisms 
that are impacted by stress system activity including promoting neuroplasticity and cognitive 
strategies to support adaptive cognitive processes. 
 Altered HPA function may be especially important in the etiology of MDD in women. 
Although there is no difference in the number of stressful life events (Young and Korszun, 
2010), or the perception of these events (Burt et al., 1988) between men and women, the cortisol 
response to stress does show sex differences, and decreases during high estrogen phases of the 
menstrual cycle (Kirschbaum et al., 1992, 1999) and during pregnancy (Altemus, 2006). Also, 
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women appear to remain more sensitive than men to lower levels of cortisol following repeated 
stressors (Vamvakopoulos, 1995; Wang et al., 2007). These findings provide evidence that 
ovarian hormone levels may modulate stress system functioning in women. Estrogen may 
support efficient and dynamic stress responding and prevent disrupted ventral-dorsal system 
interactions through supporting neuroplasticity in prefrontal areas and hippocampus. Maintaining 
function in dorsal system structures preserves regulatory control over ventral activity 
(particularly the amygdala) and allows for the efficient return to a non-stressed state. Loss of 
dorsal system function may predispose the brain to rely on ventral system processes which bias 
attention and memory towards negative information and prolongs emotional, endocrine, and 
autonomic stress responding aberrantly. Periods of increased stress sensitivity, due to ovarian 
hormone changes, may present windows of vulnerability to mood dysregulation in women who 
are at risk for MDD.  
 
1.5 Hypothalamic-Pituitary-Gonadal Axis 
 Depressive symptoms and depressive episodes in women appear to be linked to ovarian 
hormone changes. Women with a history of depression are more likely to experience increased 
depressive symptoms during periods of ovarian hormone fluctuation than at other times (Young 
and Korszun, 2002). Also a history of MDD increases a woman’s risk for mood disorders that 
are directly associated with ovarian hormone changes including premenstrual mood disorder 
(Halbreich et al., 1986, 1984), postpartum (Reich and Winokur, 1970) and perimenopausal 
depression (Freeman et al., 2014). Even in healthy women, low estrogen phases of the menstrual 
cycle are associated with increased symptoms of negative mood (Gonda et al., 2008). Women 
20 

with MDD and reproductive phase-related mood disorders generally have normal ovarian 
hormone levels (O’Toole and Rubin, 1995; Schmidt and Rubinow, 2010; Schmidt et al., 1998), 
indicating that these disorders aren’t directly contributable to abnormally low estrogen (Young et 
al., 2000). While most women do not develop mood disorders as a result of ovarian hormone 
changes, the increased risk for first onset depression as estrogen declines during the late 
perimenopause (Bromberger et al., 2010; Harsh et al., 2009; Schmidt and Rubinow, 2010), and 
the relation of premenstrual dysphoric disorder to the low estrogen phase of the menstrual cycle 
(Steiner et al., 2003), suggests that some women are susceptible to mood dysregulation as a 
result of normally low estrogen levels. It may be that the role of estrogen in MDD is 
characterized by altered brain response to circulating levels rather than differences in estrogen 
levels. 
 The hypothalamic-pituitary-gonadal axis is a multilevel hormonal system that regulates 
the secretion of ovarian hormones in females (estrogen and progesterone) through multiple 
feedback mechanisms at the ovary, pituitary, and brain (for review see Vadakkadath Meethal and 
Atwood, 2005). Gonadotropin releasing hormone (GnRH) from the hypothalamus induces the 
release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the anterior 
pituitary. LH and FSH modulate the ovarian cycle, with FSH stimulating follicle maturation and 
the release of estrogen during the follicular phase and LH triggering ovulation as well as 
progesterone release from the corpus luteum (ruptured follicle) during the luteal phase. Estrogen 
feedback to the pituitary and hypothalamus controls the release of GnRH, FSH, and LH and this 
system of feed forward and feedback mechanisms orchestrates activity within the HPG system 





Figure 2:  Ovarian Hormones 




Women experience dramatic changes in cyclic ovarian hormones across the lifespan. 
During reproductive life estrogen and progesterone levels fluctuate across the monthly menstrual 
cycle. During the early follicular phase and menstruation both estradiol (the main circulating 
estrogen in non-pregnant reproductive aged women) and progesterone levels are low. Estradiol 
increases in the mid to late follicular phase prior to ovulation. Estradiol levels decrease 
immediately following ovulation, and both estradiol and progesterone levels increase during the 
luteal phase until menstruation. Outside of the periovulatory phase, progesterone fluctuations 
parallel those of estradiol, thus it is difficult to ascertain that separate effects of progesterone in 
studies of endogenous ovarian hormones. Progesterone generally appears to antagonize that 
effect of estradiol on mood and cognition (Greendale et al., 1998; Resnick et al., 1998; Toren et 
al., 1996), however progesterone effect have been much less studied. 
 The reproductive life phase is both preceded and followed by hypogonadal states prior 
to puberty and during menopause. The menopause transition is characterized by irregular ovarian 
hormone fluctuations; both estradiol and progesterone levels can vary dramatically during the 
early transition period (which may last years), and generally settles into a stable low estradiol 
state proximal (within 6 months) to the final menstrual period. This variability in ovarian 
hormones during the reproductive years and menopausal transition creates a dynamic 







1.6 Estrogen in the Brain 
 Estrogen has a variety of effects at the cellular level including genomic actions, 
interaction with second messenger and G-protein systems, effects on calcium signaling, and 
neuroprotection (McEwen et al., 2012). Classical nuclear receptors (ERα and ERβ) are ligand-
dependent transcription factors that interact at estrogen response elements on DNA and result in 
cascades of intra-cellular reactions which alter protein synthesis (Greene et al., 1986; Kuiper et 
al., 1996). These actions are relatively slow, but result in long-lasting changes at the synapse or 
in neural function (Luine, 2014). Recently, membrane-bound estrogen receptors have been 
discovered that may activate signaling pathways and have rapid effects on the order of seconds 
and minutes (Kelly and Levin, 2001; Kelly et al., 2003). These membrane-bound receptors are 
found in the prefrontal cortex and hippocampus, and may be responsible the acute effects of 
estrogen on cognition (Luine, 2014).  
Estrogen modulation of overlapping and interacting systems for stress responding and 
emotional and cognitive processing of information provides a number of pathways through 
which estrogen fluctuations may contribute to MDD risk. In women with MDD vulnerability, 
estrogen may support healthy function of these systems, while having little or opposite effects 
for women in whom these systems are already functioning optimally. Periods of low estrogen 
may represent windows of risk to depressive episodes in women with a previous history of MDD 
because of differential effects of estrogen on mood regulation, stress, and cognitive systems 
(Newhouse and Albert, 2015). Understanding the interactions of vulnerability to MDD, stress, 
and estrogen will be important for developing more effective prevention and treatments for 
women with MDD. 
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1.6.1 Estrogen and Emotion Processing 
 Sex differences in evaluating and responding to emotional information provides a basis 
for understanding the effects of ovarian hormones on emotional processing in women. It is 
important to note that androgens are aromatized to estrogen in the brain so that men generally 
experience constant high estrogen activity in the brain, while women experience fluctuations in 
estrogen including periods of low estrogen (Fink et al., 1998). Thus, emotional processing in 
men may represent the effects of high estrogen (although interactions with organizational sex 
differences must be considered). Accordingly, sex differences in emotional processing are most 
apparent when men are compared to women during low estrogen. Neuroimaging studies of 
emotion detection or recognition show sex differences in brain regions used during these tasks, 
with women showing greater limbic, inferior frontal, and temporal activity and men showing 
greater prefrontal and parietal activity (Whittle et al., 2011). It has been suggested that this 
difference in activation patterns during emotion recognition may indicate that men and women 
perceive emotion at different levels of visual processing (Hall et al., 2004). Greater limbic 
activity in women suggests that emotion perception occurs at a primary level, while emotion 
perception in men occurs at a secondary level involving the prefrontal areas. This sex difference 
in emotion perception may contribute to the speed and accuracy advantage in women (especially 
for identifying negative emotions such as fear and anger) (Hampson et al., 2006; Merten, 2005; 
Montagne et al., 2005; Thompson and Voyer, 2014), as emotion recognition occurs early in 
visual processing, while in men emotion detection requires additional information about the 
learned significance of emotional facial expressions (Whittle et al., 2011).  
Earlier recognition of negative emotional information in women may influence women’s 
ability to regulate emotional responses to such stimuli. Enhanced emotional detection at lower 
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levels of processing may represent greater signal driven automatic activity in the ventral system 
in women that requires greater top-down modulation to maintain adaptive mood responses. 
Earlier detection of emotional information and greater amygdala activity to negative information 
in women suggest that emotional evaluative processes in women are predominated by ventral 
system activity. Regulation of ventral system activity in women may be particularly important 
for healthy mood and supported by estrogen’s action in the dorsal system, while loss of estrogen 
may predispose emotional responding through the ventral system. 
 Generally studies of passive viewing of emotional images or words have found that 
women are more reactive to emotional stimuli whether measured through self-report, behavioral 
response, physiological response, or neuroimaging (Kret and De Gelder, 2012; Whittle et al., 
2011). The sex difference appears to be specific for negative emotional information, with 
consistent findings of greater amygdala activity during negative images or words in women 
(regardless of valence or arousal ratings) (Whittle et al., 2011). Sex differences in activation 
patterns during encoding and recalling emotional information indicate greater overlap in activity 
in brain areas that are involved in processing current emotional experiences and encoding 
emotional information into memory in women including limbic, insular and prefrontal regions 
(Damasio et al., 2000; George et al., 1996; Piefke et al., 2005). In women this overlap in activity 
correlates with subsequent successful memory recall (Canli et al., 2002), suggesting that 
differences in memory encoding for emotional information may contribute to better memory for 
emotional experiences in women than men. More integrated brain circuits for emotional and 
cognitive processes may enhance attention and memory for emotional information and contribute 
to a cognitive vulnerability for depression in women. 
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 Sex differences in emotion processing and responding are modulated by ovarian 
hormone fluctuations, indicating that these processes and vulnerability to mood dysregulation 
may be influenced by circulating ovarian hormones. Sex differences in emotion recognition 
(Hampson et al., 2006) are reduced during high estrogen in women (Derntl et al., 2008), 
suggesting that estrogen enhances emotional processing through higher-level association 
pathways and may support healthy mood responding to emotional information. High estrogen 
levels reduce ventral activity (Derntl et al., 2008; Goldstein et al., 2005; Pearson and Lewis, 
2005) Fluctuating ovarian hormones in women alter the perception of emotionally valenced 
information and the mood and cognitive responses to such information. In healthy women these 
changes may be experienced as the “normal” mood changes that accompany periods of low 
estrogen, however in a subset of vulnerable women they may contribute to increased depression 
risk. Although studies demonstrate that estrogen attenuates emotional processing and supports 
mood regulation in healthy women, the effects of estrogen in women with current or remitted 
MDD, in whom ventral-dorsal interactions are likely altered, remain unclear. 
1.6.2 Estrogen and Cognition 
 In addition to the putative indirect effects through emotional processing, estrogen may 
directly modulate cognitive processes that are altered in MDD (Halbreich et al., 1995). Cognitive 
declines in a number of cognitive domains including attention an processing speed following 
menopause are greater than would be expected from the effects of age alone (Halbreich et al., 
1995 b), indicating that estrogen has positive effects on cognition that diminish as estradiol 
declines in menopause. Consistent findings of cognitive decline and increased risk for dementia 
in women who undergo early menopause, and thus experience a greater period of life with low 
ovarian hormone levels, further supports a negative impact of estrogen loss beyond the effects of 
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age in older women (Farrag et al., 2002; Nappi et al., 1999; Rocca et al., 2008). In meta-analyses 
estrogen replacement generally benefits cognition in young postmenopausal women (Hogervorst 
and Bandelow, 2010; Maki, 2005) and following oophorectomy (Bove et al., 2014; Phillips and 
Sherwin, 1992; Rocca et al., 2008; Sherwin, 1988; Sherwin and Gelfand, 1985), while combined 
estrogen and progestin treatments have little or negative effect Hogervorst and Bandelow, 2010) 
indicating that estrogen withdraw at menopause is a significant factor in cognitive decline with 
age in women (for review see: Maki and Dumas, 2009; Newhouse and Dumas, 2015; Sherwin 
and Henry, 2008).  
 Studies examining the effects of estrogen fluctuation across the menstrual cycle indicate 
that performance on tasks that rely on the hippocampus and prefrontal cortex are enhanced 
during high estradiol phases of the menstrual cycle (Sundström, Poromaa, and Gingnell, 2014) 
including cognitive control, response inhibition (Colzato et al., 2010, 2012), and verbal 
(Rosenberg and Park, 2002) and spatial memory (Hampson and Morley, 2013). Suppression of 
estradiol in young women causes reductions in blood flow and metabolism to frontal regions 
which are restored with estradiol administration (Berman et al., 1997), demonstrating that even 
acute and short-term changes in estrogen may impact dorsal region function (Craig and Murphy, 
2007). 
Estrogen’s effects at the amygdala and hippocampus may alter processing and 
subsequent memory for emotionally valenced information. Memory for emotional information is 
enhanced during menstrual phases when estradiol is low and progesterone is high (Ertman et al., 
2012). Of note is that memory is not only enhanced for the emotional content, but also for 
peripheral information (Nielsen et al., 2013), indicating that low estradiol may enhance 
attentional vigilance for emotional information and more strongly associate previously neutral 
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information with emotional information. This linking of neutral and emotional information in 
memory may underlie spontaneous intrusive recollections in PTSD or rumination in depression. 
Intrusive recollections are more common for traumatic events that occur during low estradiol/ 
high progesterone phases of the menstrual cycle (Bryant et al., 2011; Ferree and Cahill, 2009; 
Ferree et al., 2011), suggesting that ovarian hormone effects on memory may contribute to 
maladaptive cognitive processes following psychosocial stress. Further evidence that estradiol 
levels and menstrual phase impact memory processes for emotional information is provided by a 
series of studies by Milad and colleagues which demonstrated that extinction of fear conditioning 
is greater during high estradiol phases of the menstrual cycle and even after acute exogenous 
estradiol administration (Milad et al., 2006, 2010; Zeidan et al., 2011). Whereas low estrogen or 
high progesterone appear to enhance emotional processing and memory for negative information, 
high estradiol supports top-down modulation of cognitive processes and may restrain ventral 
participation in attention and memory.  
 
1.7 Potential Mechanisms of Estrogen’s Role in MDD 
Acting at nuclear and membrane-associated receptors allows estrogen to have both rapid 
and long-term effects on neuronal function, as well as varied modes of action in brain regions 
that are important for emotional and cognitive processes. There are a number of mechanisms 
through which ovarian hormones may affect brain function; including modulating 
neurotransmitter system functions and neurotrophic effects that promote neuronal plasticity 
(Rubinow and Schmidt, 1995, 2006; Schmidt and Rubinow, 2010). Estrogen interactions with 
and modulation of serotoninergic and cholinergic neurotransmitter systems have particular 
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relevance as putative mechanisms that intersect with estrogen’s support of dorsal regulatory 
system function. 
 
1.7.1 Neurotransmitter Systems 
Commonly used antidepressant medications alter synaptic levels of the monoamines 
serotonin and norepinephrine or alter receptors for these neurotransmitters (Stahl, 1998). The 
effectiveness of these treatments accord with the monoamine hypothesis of MDD that altered 
levels of serotonin or norepinephrine underlay the etiology of depression (Schildkraut, 1973; 
Schildkraut et al., 1969). Norepinephrine from the locus ceruleus has projections to frontal and 
limbic regions (Moore and Bloom, 1979) and appears to participate in a number of stress system 
feedback loops with effect on arousal and sympathetic activity (Gold, 2015). There is some 
evidence that estrogen increases central norepinephrine levels (Etgen and Karkanias, 1994) and 
that the reduction of hot flashes following hormone replacement in menopausal women may be 
due to estrogen’s effect on norepinephrine (Archer et al., 2011). However, estrogen-
norepinephrine interactions and the role of these effects in depression has been little studied 
(Borrow and Cameron, 2014; Genazzani et al., 2005). The effects of estrogen on the serotonergic 
system has been more studied and is one of the strongest candidate mechanisms by which 
estrogen influences depression (Borrow and Cameron, 2014) 
 Studies using tryptophan depletion (which decreases central serotonin) demonstrate that 
lower serotonin levels are more likely to precipitate depressive symptoms in women than in men 
(Booij et al., 2002; Ellenbogen et al., 1996; Moreno et al., 2006), however this sex difference 
was not seen following norepinephrine depletion (Moreno et al., 2006), suggesting that serotonin 
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dysfunction may be of particular importance to MDD in women. The antidepressant and SSRI 
augmentative effects of estrogen in women also suggest that estrogen may have beneficial mood 
effects through action on the serotonergic system (Halbreich et al., 1995a). In animal models, 
ovariectomy reduces and estrogen add-back increases serotonin receptors in the dorsal raphe 
nucleus (Sumner and Fink, 1993), anterior frontal, and cingulate regions (Sumner and Fink, 
1995). This experimental finding is paralleled by an increased density of serotonin receptors in 
the forebrains of female rats during natural pro-estrus when endogenous estrogen levels are high 
(Sumner and Fink, 1997). Further evidence that the presence of estrogen alters serotonin function 
in the brain arises from studies of androgens in male animals. Testosterone, but not non-
aromatizable androgens, in male animals increase serotonin receptor density (Sumner and Fink, 
1998) suggesting that the effects of testosterone on serotonin function are mediated through 
aromatization of testosterone to estrogen.  
In women, serotonin responsivity is reduced after menopause and restored following 
estrogen treatment (Halbreich et al., 1995b). While studies of estrogen alone as an antidepressant 
agent in peri and postmenopausal depression have had inconsistent findings (Cohen et al., 2003; 
Morrison et al., 2004; Rasgon et al., 2001; Schmidt et al., 2000; Soares et al., 2001; Stahl, 2001), 
estrogen-serotonin interactions may impact depressive symptoms or vulnerability to MDD 
through the cognitive and mood regulatory functions of the serotonergic system. Tryptophan 
depletion impairs the consolidation of episodic memory (Mendelsohn et al., 2009), reduces 
activity in brain areas important to the encoding of memory (hippocampus) (van der Veen et al., 
2006), and induces negative memory and attentional bias (Delgado et al., 1989; Roiser et al., 
2008) and difficulty with autobiographical memory (Haddad et al., 2009; Hayward et al., 2005) 
in remitted depressed individuals. These cognitive changes under reduced serotonin support the 
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hypothesis that diminished serotonin function may contribute to cognitive mechanisms of 
depression, such as preferential processing of and memory for negative information. Epperson 
and colleagues have shown that estrogen treatment reduces the effects on tryptophan depletion 
on brain activity during both verbal working memory and emotion recognition tasks, suggesting 
that estrogen supports serotonergic cognitive function (Epperson et al., 2012).  
Tryptophan depletion generally has little mood effect in healthy individuals (Young, 
2013) however, mood effects are common in individuals with remitted MDD or family histories 
of MDD (Booij et al., 2003; Ruhé et al., 2007; Young and Leyton, 2002). Increased risk for 
mood dysregulation during periods of low estrogen may be due to the loss of estrogen support of 
the serotonergic system (Halbreich et al., 1995b) or indirect effects on shared pathways (Schmidt 
and Rubinow, 2010).  
Estrogen’s pro-cognitive effects may be mediated though interactions with the 
cholinergic system which is critical for global cognitive function, including primary processes 
such as attention and memory which underlie higher order cognition. Loss of cholinergic 
function appears to be one of the primary mechanisms of cognitive change in pathological aging, 
particularly the memory detriments seen in Alzheimer’s disease (AD) (Grothe et al., 2015; 
Iraizoz et al., 1999; Schliebs and Arendt, 2006; Whitehouse et al., 1982). Cholinergic function 
modulates both bottom-up and top-down attentional processes, and is thus involved in cognitive 
processes that require the differentiation of relevant and irrelevant information and the efficient 
allocation of attentional resources (Gibbs, 2010; Sarter and Bruno, 1997; Sarter et al., 2003).  
In animal models ovariectomy produces poor performance on learning and memory 
tasks paralleled by a decline in cholinergic activity and choline acetyltransferase levels in several 
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brain regions including basal forebrain neurons projecting to the hippocampus (Gibbs, 2010; 
Luine and Rodriguez, 1994; O’Malley et al., 1987) and treatment with estrogen replacement 
restores these markers (Gibbs, 2000; Luine, 1985). Estrogen replacement in ovariectomized 
animals counteracts the negative effects of cholinergic antagonists on spatial learning and 
memory (Gibbs, 2000a; Luine, 1985). Studies in postmenopausal women similarly demonstrate 
that estrogen replacement protects against impaired verbal working memory, episodic memory, 
learning, and attention following cholinergic antagonism (Dumas et al., 2006, 2008, 2012). 
However the beneficial effect of estrogen is only seen in animals with relatively intact 
cholinergic systems (Gibbs, 2002, 2007), suggesting that estrogen modulates cholinergic 
function rather than acting through a separate parallel mechanism. Estrogen’s support of 
cholinergic function may essentially increase cognitive resources and maintain dorsal regulation 
of emotional cognition. 
 
1.7.2 Estrogen Effects in the Dorsal Regulatory System 
  The amygdala has reciprocal interactions with the prefrontal cortex and hippocampus, 
such that amygdala activity suppresses activity in dorsal regions. During the healthy stress 
response these reciprocal interactions allow for quick evaluation and response to stressors, 
however these feed-forward systems may become dysregulated; reduced dorsal activity releases 
amygdala inhibition and may have long-term negative effects on dorsal region structure and 
function (Gold, 2015). Loss of estrogen support for dorsal system functioning may contribute to 
this dysregulation and thus increase depression risk in vulnerable women. 
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 The hippocampus is uniquely situated at the intersection of cognitive, emotional, and 
endocrine circuits and thus may have a particularly central role in vulnerability to MDD. 
Hippocampal structure appears to be sensitive to depression history; a meta-analysis of imaging 
studies in depression found that reduced hippocampal volume is a consistent finding in 
individuals with MDD (Videbech and Ravnkilde, 2004). Furthermore, hippocampal volume 
reduction is associated with depression recurrence with smaller volume in individuals with more 
past episodes (Sheline et al., 1996) and longer illness duration (Colla et al., 2007). Whether 
smaller hippocampal volume is the result of depression or rather a marker of vulnerability due to 
developmental differences (Lupien et al., 2007) remains unclear, however the association 
between depression history and hippocampal structure accords with the hippocampus as a central 
component of overlapping networks for endocrine regulation, emotion, and cognitive processes 
that are integral to MDD etiology. 
 Estrogen may support adaptive mood regulation through effects on hippocampal 
functioning and neuronal plasticity. Estrogen has been shown to increase the density of dendritic 
spines on CA1 pyramidal neurons (especially following neuronal damage or estrogen loss 
(McEwen et al., 1995; Woolley, 1999; Woolley and McEwen, 1992) ), and estrogen receptor 
antagonists block this effect (McEwen et al., 1999). Estrogen receptor localization to the plasma 
membrane in dendritic shafts and spines (McEwen et al., 1995; Woolley and McEwen, 1992) 
suggest that estrogen may have local effects on plasticity in the hippocampus. The presence of 
estrogen appears to prime the neuron for new synapse creation through an increase in dendritic 
spines, however these new spines are only maintained following synapse activation (Woolley, 
1998, 2000; Woolley and McEwen, 1992; Woolley et al., 1997) ; estrogen does not globally 
increase hippocampus synapses, but supports the production and maintenance of synapses that 
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are used. Additionally, estrogen treatment protects hippocampal synapses from the detrimental 
effects of acute cortisol increases (Ooishi et al., 2012). Paralleling to these structural changes, 
estrogen replacement in animal models improves performance on cognitive tasks that are 
hippocampally mediated (Gibbs, 2000b; Inagaki et al., 2010; Luine and Rodriguez, 1994). 
Similarly, cognitive performances changes across the menstrual cycle and with estrogen 
replacement in postmenopausal women suggest that ovarian hormones have specific effects on 
cognitive tasks that rely on hippocampal function. 
 Estrogen receptor density in the hippocampus responds dynamically to ovarian 
hormone changes; increasing in dendritic spines during low estrogen phases of the estrous cycle 
and decreasing during high estrogen phases (McEwen et al., 2012). These changes in ER density 
may be part of a coping mechanism that maintains stable hippocampal function across estrogen 
fluctuations. A deficit in this dynamic response to estrogen changes may be associated with 
increased vulnerability to mood and anxiety disorders in some women. 
  Estrogen has similar effects on cholinergic and serotonergic functioning that may 
converge in the dorsal system that are supported by these neurotransmitter systems. In 
postmenopausal women, estradiol treatment prevents anticholinergic impairment in memory and 
attention tasks (Dumas et al., 2006, 2008, 2012), indicating that estrogen’s support of cholinergic 
function benefits prefrontal and hippocampal function. Similarly, estrogen replacement in 
postmenopausal women increases serotonin tone in the hippocampus (Compton et al., 2008), 
prefrontal cortex, and anterior cingulate, paralleled by improvements in tasks of executive 
function and verbal memory (Kugaya et al., 2003). Estrogen’s effects in the prefrontal cortex 
may modulate executive function thus having global implications for cognition and emotional 
response regulation. Neuroimaging studies examining the effects of estrogen replacement in 
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postmenopausal women show that estrogen replacement enhances hippocampal and prefrontal 
activity during tasks in which estrogen treatment improves performance (episodic memory and 
working memory encoding) (Joffe et al., 2006; Maki and Resnick, 2000; Resnick et al., 1998; 
Shaywitz et al., 1999). Additionally, ovarian hormone suppression in young women impairs 
executive function and cognitive flexibility and decreases metabolism in prefrontal, temporal, 
and parietal regions (Berman et al., 1997). Enhanced function in these dorsal system regions may 
support higher order cognitive resources and decrease automatic emotional processing or provide 
better top-down regulation of emotional responses.  
 
1.8 Introduction to Current work 
 Although the sex difference in MDD and concurrence of ovarian hormone fluctuation 
with increased risk for mood disorders in women suggest that estrogen may have a significant 
role in MDD, how estrogen influences depression vulnerability is not clear. Perhaps estrogen’s 
role in MDD can be best understood through examining estrogen’s role in emotional and 
cognitive processes that are integral to healthy mood. MDD is characterized by dysfunction in 
mood regulation and endocrine responses to stress and negative emotional information. These 
core symptoms are indicative of altered function in proposed systems for emotional evaluation 
and response (ventral system) and regulation of emotional and cognitive processes (dorsal 
system).  
The ventral and dorsal systems are interconnected and work to manage acute responses 
to environmental stimuli and coordinate long-term cognitive consequences through attention and 
memory. As detailed in Gold’s model, dysphoric mood is a natural and healthy response to 
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stress, however the ability to efficiently return to normal ventral-dorsal system dynamics and 
euthymic mood confers resilience (Gold, 2015). Healthy stress responses acutely bias stimuli 
processing towards automatic ventral evaluation and response pathways. Consistent findings of 
endocrine dysregulation in the HPA axis and the relation of stressful life event to depressive 
episodes indicate that in MDD stress system function is dysregulated with possible consequences 
for cognitive processing of emotional information. When information must be evaluated quickly, 
such as during stress, altered brain networks in MDD may be prone to ventral activity, resulting 
in enhanced attention and cognitive processing of negative information along with dysphoric 
mood. According to cognitive models of MDD, these alterations remain during remission and 
contribute to continued recurrence risk, especially following psychosocial stress.  
Evidence of estrogen’s positive effects on both cognitive and emotional processes in 
dorsal system structures indicates that estrogen supports healthy functioning in dorsal regions 
(particularly hippocampus and prefrontal cortex). Estrogen’s effect of enhancing dorsal system 
function may attenuate ventral system activity or allow dorsal system regions to regain 
regulatory function more efficiently. Conversely, low estradiol reproductive phases in women 
and loss of estrogen support of dorsal systems may predispose brain activity to ventral system 
automatic processing. Sex differences in emotion recognition suggest that women recognize and 
respond to emotional information at earlier stages in visual processing, before modulation by 
dorsal system and integration with associative information. Loss of estrogen support for dorsal 
systems may bias emotional processing to these lower-level automatic systems predominated by 
amygdala activity and enhance the salience of negative emotional information, thus increasing 
depression risk in vulnerable women.  
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The general aim of this dissertation was to investigate the role of estrogen in the 
cognitive and emotional processes that are associated with depression to better understand the 
greater prevalence of MDD in women. Previous studies indicate that in healthy young women 
endocrine response to physical and psychosocial stress is altered across that menstrual cycle and 
by hormonal contraception. However, the neural processes that are associated with psychosocial 
stress responding and the effects of estrogen on brain systems that are involved in emotional and 
cognitive responses to psychosocial stress in women have not been examined. Additionally, 
whether estrogen’s effects on endocrine response to stress are related to mood response to stress 
has not been investigated. In Chapter 2 of this dissertation, the effect of menstrual phase and 
estradiol level on the neural and mood response to psychosocial stress in young, normally 
cycling women was investigated. We hypothesized that high estradiol around ovulation reduces 
negative mood response and dorsal system deactivation during psychosocial stress compared to 
low estradiol during the early follicular phase around menstruation. 
Cognitive models of MDD posit that altered cognitive processing of emotional 
information maintains negative mood in depressive episodes and confers recurrence risk during 
remission. Attention and memory bias for negative information is a consistent finding in studies 
of currently depressed individuals. Attention bias and the postulated relation to enhanced 
amygdala activity that remains in remitted MDD has been less studied. In Chapter 3 the effect of 
MDD history on neural response and attention to emotionally valenced images was investigated. 
We hypothesized that women with a history of MDD would show enhanced amygdala activity 




1.9 Magnetic Resonance Imaging Methodology 
Magnetic resonance imaging (MRI) produces images of biologic tissue through the use 
of strong magnetic fields (for review seeHuettel, et al. 2009).  Because the body has a high water 
content (50-60% by weight), MRI is commonly implemented to detect and measure signals 
based on the properties of hydrogen nuclei (protons) in magnetic fields. Hydrogen protons have a 
positive electric charge that creates a small magnetic field as they spin. These magnetic fields are 
normally randomly directed and thus the net magnetization is nearly zero. In MRI a strong 
magnetic field tuned to the frequency of hydrogen protons induces alignment of the magnetic 
spins and increases the net magnetization of hydrogen protons in the body. Once the magnetic 
spins of the hydrogen protons are aligned, energy can be applied to the system and the release of 
that energy as the system returns to a lower energy state can be measured to provide information 
about biologic tissues.  
For both structural and function MRI, radio frequency pulses are applied to the target 
tissue (for the purposes of the following studies that target will be the brain). Radio frequency 
applied to the brain perturbs the equilibrium state created by the static field and the energy from 
these pulses are absorbed by hydrogen protons. Hydrogen protons release the radio frequency 
energy and realign with the static magnetic field; the release of this energy can be detected and 
defines the raw MRI signal.  
The time that it takes for proton spins to realign with the static magnetic field is unique 
to each tissue type because of local magnetic field inhomogeneities. The difference in energy 
released over time between tissues allows for the detection of tissue types in structural MRI. 
Local magnetic properties are also disturbed by difference in blood oxygenation in and near 
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tissue. These local disruptions in magnetic field affect the time to return to alignment with the 
static field and are the basis for blood oxygen level-dependent (BOLD) imaging used in function 
MRI (fMRI). In areas of increased neural activity blood flow increases to supply oxygen for 
aerobic metabolism. Blood flow to active areas is increased beyond the need for oxygen so that 
areas of increased activity have higher levels of oxygenated blood relative to less active areas. 
Deoxygenated hemoglobin has unbound electrons in the iron within the heme group and is thus 
diagmagnetic. Because of the diamagnetic properties of deoxygenated hemoglobin, realignment 
of hydrogen protons with the static field occurs faster in less active than more active areas. 
Measuring radio frequency energy released at a time lag after realignment by less active areas 
but before realignment by more active areas allows for the identification of areas of increased 
neural activity.  
These imaging techniques are combined with carefully designed tasks for task-related 
fMRI which identifies areas of the brain that are presumed to be active during particular brain 
functions or cognitive processes. Resting fMRI is used to identify functional connectivity 
between brain regions and networks. During resting fMRI BOLD imaging is implemented 
without the participant explicitly performing a task. Spontaneous activity is measured and the 
activity in different brain regions is analyzed for correlated time courses which are interpreted as 
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Although ovarian hormones are thought to have a potential role in the well-known sex 
difference in mood and anxiety disorders, the mechanisms through which ovarian hormone 
changes contribute to stress regulation are not well understood. One mechanism by which 
ovarian hormones might impact mood regulation is by mediating the effect of psychosocial 
stress, which often precedes depressive episodes and may have mood consequences that are 
particularly relevant in women. In the current study, brain activity and mood response to 
psychosocial stress was examined in healthy, normally cycling women at either the high or low 
estradiol phase of the menstrual cycle. Twenty eight women were exposed to the Montreal 
Imaging Stress Task (MIST), with brain activity determined through functional magnetic 
resonance imaging, and behavioral response assessed with subjective mood and stress measures. 
Brain activity responses to psychosocial stress differed between women in the low versus high 
estrogen phase of the menstrual cycle: women with high estradiol levels showed significantly 
less deactivation in limbic regions during psychosocial stress compared to women with low 
estradiol levels. Additionally, women with higher estradiol levels also had less subjective distress 
in response to the MIST than women with lower estradiol levels. The results of this study 
suggest that, in normally cycling premenopausal women, high estradiol levels attenuate the brain 
activation changes and negative mood response to psychosocial stress. Normal ovarian hormone 
fluctuations may alter the impact of psychosocially stressful events by presenting periods of 
increased vulnerability to psychosocial stress during low estradiol phases of the menstrual cycle. 
This menstrual cycle – related fluctuation in stress vulnerability may be relevant to the greater 





The sex difference in affective and stress-related disease rates (2 to 3 times greater 
incidence and prevalence of major depression in women compared to men (Bromet et al., 2011; 
Kessler et al., 2005)) emerges at puberty and remains until menopause (Kessler et al., 1994). The 
stress exposure model of depression suggests that MDD is the result of a vulnerability to 
depression, combined with the trigger of stressful life events (Hankin et al., 2007; Liu and Alloy, 
2010). Accordingly, psychosocial stressors are among the top reported antecedents to depression 
episodes (Frank et al., 1994; Kendler et al., 1999, 2000), and dysregulation of the hypothalamic-
pituitary-adrenal (HPA) axis response is a consistent finding in major depression (Burke et al., 
2005; Lupien et al., 2005). Psychosocial stress may be especially important in the etiology of 
mood disorders in women as the depressogenic effects of life stressors are reportedly greater in 
women than men (Mezulis et al., 2010), even when there is no difference in the number of 
stressful life events or in the subjective perception of these events (Young and Korszun, 2010). 
Although this finding is consistent and has been replicated by studies across the globe (Bromet et 
al., 2011), the reasons for the sex difference in incidence and prevalence of mood and anxiety 
disorders are not well understood.  
 The cortisol response to stress shows consistent sex differences (Vamvakopoulos, 1995), 
and changes across the menstrual cycle, decreasing during the late follicular phase when 
circulating estrogen is high (Kirschbaum et al., 1992, 1999). Women are more likely than men to 
show variations in HPA function in response to stressors (Weiss et al., 1999) and during 
depressive episodes (Young and Korszun, 2010). These differences in stress system response 
likely contribute to mood disorder risk in women (Weiss et al., 1999), and may be modulated by 
ovarian hormone fluctuations across the menstrual cycle (Kajantie and Phillips, 2006; Roca et 
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al., 2005). The role of corticosteroids in stress response and regulation is well known, however 
the effects of gonadal steroids (e.g. estradiol) –which may be specifically important in women- 
are less well characterized. .  
The concurrence of increased major depressive disorder (MDD) and post-traumatic stress 
disorder (PTSD) risk in women during the reproductive period of life suggests that the cyclic 
fluctuation of ovarian hormones during this period may contribute to the risk for 
psychopathology. Understanding the role of ovarian hormones in emotional processing and 
mood regulation in women may provide important insight into the mechanisms underlying the 
stress response and potentially the increased incidence of MDD and PTSD in women.  
Ovarian hormones may modulate the effects of stress on mood. Brain areas that are 
central to mood regulation (including the amygdala and hippocampus) show some of the largest 
densities of estrogen receptors in the human brain (Merchenthaler et al., 2004; Ostlund et al., 
2003); interestingly, those areas are also very rich in cortisol receptors. Estrogen may modulate 
the activity of these areas; large community and clinic based studies indicate that negative mood 
complaints (Davydov et al., 2005; Gonda et al., 2008) (even in healthy women) and suicidal 
behavior (Baca-Garcia et al., 2004; Saunders and Hawton, 2006) increase in women during low 
estrogen phases of the menstrual cycle. Brain activity related to processing negative emotional 
information is also modulated by changing estradiol levels across the menstrual cycle (Goldstein 
et al., 2005; Merz et al., 2012), suggesting that estrogen may alter the mood response to negative 
information, making this information more or less salient to cognitive processes and 
subsequently mood states. 
Although there is strong evidence that estrogen modulates the response to negatively 
valenced stimuli, such as negative images (Andreano and Cahill, 2010; Goldstein et al., 2005), 
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the effect of estrogen on the response to psychosocial stress is less well understood. Psychosocial 
stress differs from processing emotional information in a number of ways - stress includes 
elements of self-esteem, uncontrollability, and personal threat. Further, studies using 
performance–based stressors provide evidence that there is a sex difference in the endocrine 
(cortisol) response to this type of stress, and that cycling ovarian hormones may modulate this 
response in women (Kirschbaum et al., 1992, 1999). Social-evaluative threat is one element of 
psychosocial stress that may be especially salient for women, and has face validity for the real 
life stressors women experience and that contribute to mood disorder risk (Kendler et al., 1999, 
2000; Stroud et al., 2002). Understanding the effect of ovarian hormones on the response to these 
types of stressors is thus important in understanding the role of ovarian hormones in the brain 
mechanisms of emotional processing and mood in women. Investigating the stress response, 
under controlled laboratory conditions, provides an opportunity to examine the effects of ovarian 
hormones on emotional processing, stress response, and subsequent mood. 
 In this study, we examined the effect of estradiol levels across the menstrual cycle on 
both the brain activity and behavioral response to a laboratory-based model of psychosocial 
stress. We hypothesized that high circulating estrogen would reduce the effect of acute stress on 
brain activity and be associated with less subjective distress following the stress-inducing task. 
Methods 
Overview:  
This cross sectional study included 28 normally cycling women (ages18-45) who were 
examined during early follicular phase (day 1-2 of menstrual cycle), or at ovulation (day 12-14), 
and who participated in a psychological stress fMRI task. Due to the psychosocial stress task 
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used in this study, and the requirement to debrief participants about the focus of the study once 
the stress task was completed, we were unable to repeat the stress task for a within subjects 
comparison, and were limited to between subjects/ group comparisons. Approximately half of 
the participants were studied at the University of Vermont and half were completed at Vanderbilt 
University. The study coordinator was the same throughout the study and the MRI scanners were 
the identical make and model, with the same software version in operation at the time of the 
study. The study procedures were identical at both Universities, and imaging and behavior data 
were analyzed for study location effects. The study was reviewed and approved by both the 
University of Vermont and Vanderbilt University Institutional Review Boards, and all 
participants provided written informed consent.   
Participants: 
Participants were recruited and told that they would be participating in a study to examine 
the effects of menstrual cycle hormone changes on mathematical ability in women. All 
participants were healthy, with regular menstrual cycles (21-35 days), no hormonal contraceptive 
or centrally active medication use, and no history of severe pain or mood changes related to their 
menstrual cycles. We excluded participants with current or past Axis I psychiatric disorders 
using the Structured Clinical Interview for DSM Disorders (Spitzer et al., 1992). Beck 
Depression Index score was required to be less than 7, and Beck Anxiety Index score less than 
15 (Beck et al., 1961). Current illicit drug use and pregnancy were exclusions.  
Screening and Characterization: 
To assure all participants were of at least average intelligence, we administered the 
Wechsler Abbreviated Scale of Intelligence (Wechsler, 1999). The Composite International 
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Diagnostic Interview for premenstrual dysphoric disorder (Kessler and Ustun, 2004) was used to 
collect menstrual cycle history and to rule out premenstrual dysphoric disorder, and physical and 
psychological symptoms associated with the menstrual cycle were assessed using the Moos 
Menstrual Distress Questionnaire (Moos, 1968). Personality factors were assessed at screening 
using the NEO Five Factor Inventory (Costa and McCrae, 2000). Following screening, 
participants tracked their menstrual cycles for three months to determine an average cycle length 
and to calculate the study day date. At the University of Vermont, participants tracked using a 
paper calendar; at Vanderbilt University, women filled in daily surveys using the on-line 
REDCap system.  
Women were randomly assigned to return for the study day during the early follicular 
phase (days 1-2 of the menstrual cycle) or at ovulation (day 12-14); before the study began, 
participant research ID numbers were assigned a randomly generated number, ranked according 
to this random number and then alternatingly assigned to the two groups . The study day took 
approximately 3 hours to complete. Upon arrival at the Clinical Research Center, participants 
completed the State and Trait Anxiety Inventories (Spielberger, 2010) and the Beck Depression 
and Anxiety Inventories (Beck et al., 1961).  
Stress Task: 
We employed the Montreal Imaging Stress Task (MIST) for psychosocial stress 
induction (Pruessner et al., 2008). The MIST produces moderate psychosocial stress through a 
combination of motivated performance and social-evaluative threat. We presented the MIST as 
an arithmetic task in the MRI scanner, and instructed participants that they should achieve an 80-
90% correct performance for their data to be usable in the context of this experiment. 
Unbeknownst to the subjects, the MIST contains an algorithm producing script that 
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automatically adjusts the difficulty of the math tasks to the aptitude of the participant, this way 
maintaining a low performance rate (between 40-50%) by changing either the problem difficulty 
or the allotted time. A “control” condition, in which the participants solve arithmetic problems 
with no time limit and no performance limit, serves as a contrast to control for brain activity 
changes induced by arithmetic task demands (visual stimuli, motor response, and mental 
arithmetic). Social evaluative threat comes from scripted experimenter interaction; the 
experimenters enter the MRI room between runs and inform the participants that they are not 
doing well enough and that they need to improve their performance for the experiment to be 
successful.  
In this study, participants completed three runs of the MIST; the MRI sessions were 
scheduled during the afternoon when baseline cortisol levels are low. After the first run, 
experimenter 1 entered the scanner room and provided the scripted feedback and asked the 
participant to complete a second run of the task. After the second run the experimenter 1 entered 
the scanner room and told the participant that the experimenter 2 (“doctor”) would like to speak 
with them about their performance, at which point the experimenter 2 entered the scanner room 
and provided the scripted feedback and asked the participant to complete a third run of the task. 
This protocol was designed to maintain both performance and social evaluative threat throughout 
the MIST and to prevent participants from habituating to the performance challenge or giving up 
on completing the task. Specifically the interaction of the participants and the experimenters was 
structured to generate psychosocial stress. To habituate the participants to the scanning 
environment and decrease scanner-related stress at the study day, participants entered an MRI 
simulator during the screening visit; in the MRI simulator, participants watched a nature video 
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while being exposed to the MRI environment (simulated MRI sounds, head coil, and being 
placed in the MRI bore) and the stimulus presentation system.  
The MIST was presented in a block design; each condition was presented twice per 3 
runs (“stress”: 100 seconds, “control”: 50 seconds, ‘rest”: 30 seconds). Participants practiced the 
MIST task (control trials only) in the MRI simulator, before the MRI session. 
 Subjective Measures 
Participants completed subjective measures: the Stress and Arousal Checklist (King et al., 
1983) (before and after the MIST), the Profile of Mood States (McNair et al., 1989), and a Visual 
Analogue Scale for mood and task experience (both after the MIST).  
Endocrine Measurements:  
Saliva samples were collected, using Salimetrics salivettes placed under the tongue, at 
seven times during the study day to assess the cortisol response to the stress task (Fig.1). 
Salivettes remained under the tongue for two minutes, and then were stored at -80°C freezer until 
analysis. Cortisol levels were assessed using the Salimetrics High Sensitivity Salivary Cortisol 
Enzyme Immunoassay Kit for quantitative determination of salivary cortisol with a sensitivity of 
0.007 ug/dL for 25µl sample volume (Salimetrics LLC, Philadelphia, PA). All cortisol 
measurements were assayed in duplicate, with mean intra-assay coefficient of variation of 7.5% 
and inter-assay coefficient of variation of 14.3%. Cortisol area under the curve measurements for 
each participant (over the study day) were calculated using Graphpad Prism.  
Blood samples were collected from each participant at the end of the study day to 
determine the estradiol level and to verify menstrual phase. Estradiol was assessed from sera 
using the Immulite 1000 endocrine panel immunoassay system with mean intra-assay coefficient 
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of variation of 5.9%. For analyses by menstrual phase, we required that both the participant’s 
menstrual cycle tracking and estradiol level indicated that they were in the assigned menstrual 
phase. Participants’ whose estradiol levels did not concord with their randomly assigned 
menstrual phase at the study day; women whose estradiol levels were higher or lower than the 
reference values for their assigned phase, were not included in the low or high estradiol groups, 
as they could not be accurately assigned to either group. These data were included in all other 
analyses. 
 Progesterone levels were assessed using the Salimetrics Salivary Progesterone (P4) 
Enzyme Immunoassay Kit with a sensitivity of 5pg/mL for 25µl sample volume (Salimetrics 
LLC, Philadelphia, PA). The first saliva sample of the day was used for progesterone 
measurements. All progesterone measurements were assayed in duplicate, with mean intra-assay 
coefficient of variation of < 1%. 
MRI Scan parameters: 
Participants were scanned on a Philips 3.0 Tesla Achieva scanner, with an 8 channel head 
coil. All participants received the following MR sequences: 1) A sagittal T1-weighted 3D Turbo 
Field Echo Sensitivity Encoding (TFE SENSE) sequence perpendicular to the anterior 
commissure (AC) -posterior commissure (PC) line, repetition time (TR) of 9.9 ms, echo time 
(TE) of 4.6 ms, a flip angle of 8°, number signal averages (NSA) 1.0, a field of view (FOV) of 
256 mm, a 256 × 256 matrix, and 1.0 mm slice thickness with no gap for 140 contiguous slices. 
2) A T2- weighted Gradient and Spin Echo (GRASE) sequence was run parallel to the AC-PC 
line, TR 2470 ms, TE 80 ms, NSA 3.0, FOV of 230 mm, 0.7 mm slice thickness with 5.0 mm 
gap for 28 slices. 3) Three Echoplanar Blood Oxygenation Level Dependent (EpiBOLD) 
functional sequences, transverse orientation, TR 2500 ms, TE 35 ms, flip angle 90°, 1 NSA for 
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FOV 240, 240X128 matrix, and 4.0 mm slice thickness with no gap, with ascending interleaved 
acquisition, for 35 contiguous slices.  
fMRI Analysis: 
fMRI data was processed using Statistical Parametric Mapping (SPM8) (Wellcome 
Department of Cognitive Neurology, 2008). Preprocessing included: realignment of the three 
functional runs and correction for bulk-head motion, coregistration of functional and anatomical 
images for each participant, segmentation of the anatomical image, and normalization of the 
anatomical and functional images to the standard MNI template, and spatial smoothing with a 
Gaussian filter (8 mm at full width, half maximum).  
Artifact detection was performed on functional images using the ART toolbox in SPM, 
and outliers for signal intensity (z>3) and motion (movement >3 mm in either translation or 
rotation) were entered as nuisance regressors at the first level, single-participant analysis. At first 
level analysis, T-maps were created from linear contrasts for task conditions and between 
condition comparisons; these T-maps were used in the second level whole-brain random effects 
analysis of participant group effects with two-sample t-tests. The preprocessed functional images 
had a voxel size of 2X2X2 mm and cluster threshold correction was used to control for multiple 
comparisons (from voxel wise p = 0.005) to corrected p < 0.001 with k = 58 (corrected voxel-
wise p = 0.000001) (from alpha simulation in REST(Song et al., 2011) toolbox for SPM, using 
whole brain mask).  
Two sets of second level analyses were conducted, one analysis with groups defined by 
menstrual phase and estradiol level at the study day, and a second analysis with groups defined 
by subjective distress to the MIST (change in Stress Arousal Checklist score). Separate 
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regression analyses were run for estradiol level and subjective distress by hippocampal activity 
(using a bilateral hippocampus region of interest mask created from the Automated Anatomical 
Labeling (AAL) in WFU Pickatlas (Maldjian et al., 2003). Percent signal change in right and left 
hippocampus was calculated with the REX toolbox for SPM; using masks created from the 
average peak cluster in the hippocampus ROI (using the contrast “control” condition > “stress” 
condition in the full subject set) with cluster threshold correction (from voxel wise p = 0.05) to 
corrected p < 0.001 with k = 101 (corrected voxel-wise p = 0.0001).  
Results 
Participants:  
Average participant age was 30.4 years (SD = 8.2 years). There was no difference in age 
between subject groups either by estradiol level (t (8) = -1.01, p = 0.33), or distress (t (26) = -
0.83, p = 0.41). No participants had Menstrual Distress Questionnaire scores that indicated 
severe premenstrual somatic or affective changes. There were no differences between any of the 
participant groups at screening, including Beck Depression Inventory scores, Beck Anxiety 
Inventory scores, NEO Five Factor Inventory personality measures, or any of the Menstrual 
Distress Questionnaire measures, and none of the participants had elevated scores on these scales 
(Table 1). For the analysis of the effect of menstrual phase on stress related brain activity, we 
included only participants whose estradiol level at the study day confirmed their assigned 
menstrual phase. The reference value for median early follicular phase estradiol levels using the 
Immulite 1000 endocrine panel immunoassay system is 31 pg/mL. Women were included in the 
low estradiol phase group if they were assigned to the early follicular group and had an estradiol 
level on the study day less than 40 pg/mL (M = 24.91 pg/mL). Women were included in the high 
estradiol phase group if they were assigned to the ovulatory group and had an estradiol level on 
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the study day greater than 50 pg/mL (M = 103.52pg/mL). This resulted in 8 participants (4 from 
the low estradiol, and 4 from the high estradiol group) not being included in stress-brain imaging 
analyses for low vs. high estradiol phase groups; these participants’ data were included in all 
other analyses 
Brain Activity - Psychosocial Stress Response 
Second level comparison using a one sample t–test of average images of all subjects (n = 
28) (using the 1st level contrast of control condition > stress condition) revealed significantly 
(uncorr p = 0.005, cluster size = 58, corr p < 0.0001) greater activation in cingulate, temporal 
(including hippocampus), and frontal regions and activation in parietal and precentral gyrus 
regions during the control condition compared to the stress condition (Fig.2 and Table 2). This 
activity pattern is consistent with the activity pattern previously shown by studies using the 
MIST (Pruessner et al., 2008); reduced activation of hippocampus and para-limbic regions 
during the stress condition. These results confirm that the overall brain activity response to 
psychosocial stress in a sample including only women is similar to the brain activity seen in 
studies that include both men and women. 
Menstrual Cycle Phase/ Estradiol Effects 
Estradiol level was significantly higher in the high estradiol phase group (M = 103.52 
pg/mL, SD = 34.09) than the low estradiol phase group (M = 24.91 pg/ mL, SD = 9.17) (t (18) = 
7.04, p < 0.001). All women had salivary progesterone levels under 105 pg/mL (M = 49.72 
pg/mL, SD = 35.54), consistent with the follicular phase (Chatterton et al., 2005). Progesterone 
levels did not differ between the low estradiol phase group (M = 48.90 pg/mL, SD = 36.10) and 
high estradiol phase group (M = 50.54 pg/mL, SD = 36.91) (t (18) = 0.099, p = 0.92) (Fig.3). 
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The fMRI estradiol phase group analysis for the effect of psychosocial stress, including 
participants who showed concordance of assigned menstrual phase and estradiol level, (high 
estradiol n = 10, low estradiol n = 10), showed a significant (uncorr p = 0.05, cluster size = 529, 
corr p < 0.005) effect of estradiol level on brain activity during psychosocial stress and perceived 
distress following the MIST, however these findings did not survive more conservative 
correction for multiple comparisons . Women with low estradiol levels had significantly less 
activity in the left hippocampus than women with high estradiol levels during the stress condition 
(Fig.4 and Table 3). This finding indicates that women in the high estradiol phase of the 
menstrual cycle have a greater left hippocampal activity during psychosocial stress than women 
in the low estradiol phase. 
Bilateral hippocampal activity during psychosocial stress was directly associated with 
estradiol levels in an analysis of the 20 participants included in the estradiol phase group analysis 
(uncorr p = 0.005, cluster size = 58, corr p < 0 .0001) with greater activity in the bilateral 
hippocampal ROI being associated with higher estradiol levels. Examining the individual right or 
left hippocampal ROIs showed that the correlation between estradiol level and percent signal 
change in either right or left hippocampus did not meet statistical significance (right 
hippocampus: r = - 0.14, n = 28, p = 0.45; left hippocampus: r = - 0.21, n = 28, p = 0.37), 
indicating that the effect of estradiol was not lateralized. 
In an analysis that included all participants grouped according to their assigned menstrual 
phase (without confirmation by estradiol level), there were no brain areas that showed greater 
activity in the periovulatory group compared to the early follicular phase group at either 




Brain Activity - Subjective Distress Effects 
To compute a group contrast for the effects of subjective distress on brain activation 
changes, we performed a median split of subjective distress scores; difference in pre vs. post 
MIST stress score on the Stress and Arousal Checklist (high distress n = 14, low distress n = 14). 
The subsequent fMRI analysis with the high and low distress groups showed an associated of 
distress and brain activity during the psychosocial stress task. Women with lower distress scores 
showed significantly more activity in bilateral hippocampus (Fig5), midbrain, left parietal, and 
left frontal regions than women with higher distress scores and (Table 4). By contrast, greater 
subgenual cingulate activity was seen in women with higher distress scores compared to women 
with lower distress scores (Table 4). These differences indicate that women who respond to the 
MIST with high subjective distress have a greater change in brain activity during psychosocial 
stress than women with low subjective distress following the MIST.  
Bilateral hippocampal activity during psychosocial stress was inversely associated with 
distress scores in an analysis of all participants (p < 0.001) with lower activity in the 
hippocampal ROI being associated with greater distress. These correlations were statistically 
significant bilaterally (left hippocampus r = 0.51, n = 28, p = 0.006, right hippocampus r = 0.49, 
n = 28, p = 0.008). We re-analyzed the correlation after step-wise removal of percent signal 
change extreme values and association between left hippocampal percent signal change and 
distress remained significant (r = 0.39, n = 28, p = 0.04) but the right hippocampus did not( r = 
0.31, n = 28, p = 0.10). 
There was no significant difference in brain activity between participants run at the two 
study locations in any of the contrasts of interest at any level of significance including 
uncorrected p < 0.05. 
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 Behavioral and Mood Measures - Estradiol Effects 
There was no effect of estradiol phase group or distress group on pre-MIST Stress and 
Arousal Checklist scores, Trait Anxiety Inventory scores, or State Anxiety scores (Table 5), and 
no effect on any of the Profile of Mood scores, Arousal scores, or any of the scales of the Stress 
Task Visual Analogue Scale following the MIST (Table 6). Distress scores (difference in SACL 
Stress score before and after the MIST) were lower in women with high estradiol than in women 
with low estradiol levels (Table 6). A multiple regression was run to predict stress change from 
estradiol level, progesterone level, and age, F (3, 24) = 4.2, p < 0.05, R2 = .344. Only estradiol 
added statistically significantly to the prediction, p < 0.05.  
Behavioral and Mood Measures - Distress Effects 
There was no significant difference between groups on Stress and Arousal Checklist 
scores, Trait Anxiety Inventory scores, or State Anxiety scores before completing the MIST 
(Table 5). Women with higher distress scores had higher scores (worse mood) on all negative 
scales of the post-task Profile of Mood States (including tension, depression, anger, fatigue, 
confusion, and total mood disturbance) compared to women with lower distress scores, 
indicating worse mood following the MIST (Table 6). Additionally, women with higher distress 
scores had significantly lower estradiol levels (M = 43.47 pg/mL, SD = 35.26) than women with 
lower distress scores (M = 74.49 pg/mL, SD = 40.93) (t (26) = 2.15, p < 0.05), and there was an 
inverse correlation between estradiol and distress with lower estradiol levels associated with 
greater distress (r = -0.50, n = 29, p = < 0.01). There was no difference in progesterone levels 
between distress groups - low distress progesterone (M = 41.04 pg/mL, SD = 35.49), high 
distress progesterone (M = 58.96 pg/mL, SD = 36.84), (t (26) = - 1.31, p = 0.20) (Fig 4).  
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There was no significant difference in any of the screening or study day subjective or 
behavioral measures between participants run at the two study locations at p < 0.05.  
Cortisol  
All subjects showed an increase in cortisol related to the MIST and cortisol AUC was 
associated with decreased medial prefrontal activity during psychosocial stress (Fig.6); however 
there was no significant correlation between estradiol level or distress score group with cortisol 
response to the MIST. Cortisol AUC showed substantial inter-subject variability with an average 
AUC for the entire sample of 0.8 and a standard deviation of 2.8. 
Discussion 
Overall, women showed brain activity patterns during psychosocial stress that were 
similar to the patterns previously seen in studies that included both men and women; deactivation 
of limbic regions (Pruessner et al., 2008). However, this study showed that higher estradiol levels 
at periovulation were associated with greater hippocampal activity during psychosocial stress in 
normally cycling premenopausal women. Menstrual cycle phase and corresponding estradiol 
levels were directly correlated with hippocampal activity during the stress condition of the 
MIST; activity in the hippocampus during stress was significantly lower in women in the low 
estradiol levels compared to women with higher estradiol levels. These results suggest that low 
estradiol levels during the early follicular phase of the menstrual cycle exaggerate the effect of 
psychosocial stress on brain activity. Women with higher periovulatory estradiol levels also had 
lower distress scores following the psychosocial stress task. Group analysis based on distress 
following the MIST confirmed the relationship between estradiol and both brain and mood 
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response to stress: women with higher distress had lower left hippocampal activity during the 
MIST, more negative mood following the MIST, and lower estradiol levels. 
Previous work using the MIST has revealed deactivations during the stress condition of 
the task, in brain areas that are part of the limbic circuit (including hippocampus, hypothalamus, 
medio-orbitofrontal cortex and anterior cingulate cortex) (Pruessner et al., 2008). These studies 
have proposed that reduced limbic circuit function is associated, perhaps causally, with the stress 
response. Additionally, hippocampal deactivation during the stress condition of the MIST has 
been directly related to cortisol release and inversely correlated with measures of self-esteem, 
indicating that hippocampal activity is a marker of both the peripheral endocrine response to 
stress and related to psychological vulnerability to psychosocial stress (Pruessner et al., 2008). 
These findings are consistent with previous studies showing that the hippocampus is an 
important inhibitor of the HPA system (Jacobson and Sapolsky, 1991). Hippocampal function is 
also important in processing emotionally valenced information (Canli et al., 2002), especially in 
women, and in evaluating the context of social interactions (Berthoz et al., 2002). Our findings 
suggest that higher circulating estradiol may support continued hippocampal activity during 
psychosocial stress.  
The brain regions that are commonly indicated in studies of major depression and in 
recent neuroimaging studies of psychosocial stress are important targets for investigating 
vulnerability to mood disorder and the interaction with stressful life events. That these same 
regions are responsive to estradiol manipulation (Andreano and Cahill, 2010; Goldstein et al., 
2005) is interesting in light of the mood effects of estradiol in both healthy women (Gonda et al., 
2008) and mood disorders related to ovarian hormone fluctuations . Estradiol has been shown to 
modulate activity on brain circuits important for emotional processing; estradiol level changes 
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across the menstrual cycle are associated with changes in brain activity related to arousal for 
negative valenced images (Goldstein et al., 2005), and in fear conditioning (Zeidan et al., 2011). 
These findings provide evidence that estradiol may affect emotional responding through 
increased top-down modulation of emotional circuitry, including brain areas involved in the 
stress response, and may be protective against fear and anxiety. Our findings suggest that greater 
estradiol levels during the periovulatory phase of the menstrual cycle decrease the brain activity 
change in response to psychosocial stress, and reduce the acute behavioral and mood 
consequences of the stress experience. This interpretation is further supported by the location of 
estradiol receptors in the central nervous system; the hippocampus is rich in both estradiol and 
glucocorticoid receptors, making it an important area of interaction between these hormones. 
 Estradiol receptors are located in a number of brain areas, including regions important 
for the autonomic, hormonal, and cognitive-emotional response to psychosocial stress (Love et 
al., 2010). The relation of stress to depression onset (Frank et al., 1994; Kendler et al., 1999, 
2000) and the altered function of the stress system in major depression (Burke et al., 2005; 
Lupien et al., 2005) suggest that modulation of the psychosocial stress response may be a 
mechanism through which estradiol fluctuation may contribute to MDD and PTSD risk. The 
results of this study suggest that estradiol levels may modulate activity in brain areas important 
for processing emotional information during psychosocial stress. Increased emotional processing 
and physiological response to psychosocial stress, during low estrogen menstrual phases, may 
contribute to depressed mood in women with vulnerability to MDD. Indeed, women with MDD 
have greater HPA axis dysregulation than men with MDD (Young and Ribeiro, 2006; Young et 
al., 1994), suggesting that the stress system may be particularly important to depression in 
women. Estradiol may attenuate sympathetic and HPA axis activity to stress (Kajantie and 
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Phillips, 2006; Roca et al., 2005). Although our study did not include women with mood 
disorders, the effect of estradiol on brain activity and mood response to psychosocial stress 
suggest that periods of low estradiol are associated with heightened negative emotional 
responding. These phases may thus present windows of increased vulnerability to the 
depressogenic effects of psychosocial stress in women. Further work is needed to determine 
whether the effects of estradiol on stress responding differ in women with vulnerability to mood 
and anxiety disorders, and if there is a relation between the occurrence of stressful events during 
different phases of the menstrual cycle and subsequent MDD or PTSD onset in vulnerable 
women. 
We recognize that menstrual cycle effects are likely not the only, or even the main, 
determinant of psychosocial stress responding in women; future studies are needed to examine 
the effects of personality factors, and lifetime trauma or chronic stress. Limitations also include 
that the separate roles and mechanisms of estradiol and progesterone in emotional processing and 
response remain to be delineated. Although we did not directly investigate the effect of differing 
progesterone levels on stress responding, we attempted to isolate the effects of estradiol by 
having women experience the psychosocial stress task during the early follicular phase or the 
periovulatory phases when progesterone levels are low. We excluded women whose estradiol 
levels were not in concordance with their assigned menstrual phase from our menstrual cycle 
phase/ estradiol fMRI analysis, as these women were likely in the mid luteal phase, when both 
estradiol and progesterone levels are increasing. The periovulatory phase is a very short duration 
of time (2-4 days) and it is possible that some women in our study were studied after ovulation. 
Indeed, brain activity during the psychosocial stress task did not show a difference between 
groups based only on assigned menstrual phase, suggesting that the women who were omitted 
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from the estradiol level-based analysis may not have been in the correct phase or that estradiol 
level rather than phase has a stronger effect on neural activity in response to psychosocial stress. 
Although we believe this approach was appropriate to investigate the effects of estradiol level, it 
resulted in a reduced sample size for the menstrual cycle phase/ estradiol level analysis. As 
progesterone levels did not appear to have an effect on distress in this study, we included all 
participants in the analyses by subjective distress. This study was not designed to investigate the 
separate effects of estradiol and progesterone by menstrual phase, however it did reveal a linear 
inverse relationship between estradiol levels and subjective distress that did not exist for 
progesterone.  
Additionally, this study did not include women who experience mood disruption directly 
related to menstrual phase or ovarian hormones (such as Premenstrual Dysphoric Disorder or 
Polycystic Ovarian Syndrome), nor did this study model these disorders. The effect of ovarian 
hormone level/menstrual phase on brain activity during emotional processes in women with 
these disorders likely differs from healthy women, and the effects on stress responding in these 
populations should be examined separately. Another potential limitation of this study is the 
difference in block length between stress and control conditions of the MIST. The stress 
conditions of the task needed to be of sufficient length to allow the stress response to develop, 
however the limitations in task time (and efficient block length) did not allow for the control 
conditions to be of similar length. We believe the control condition was of sufficient length and 
had enough repetitions to use as a comparison to isolate brain activity related to the stress 
response. 
This study is unique in that that we used a moderate psychosocial stressor in the MRI 
environment at different menstrual phases, which allowed us to examine both the subjective 
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mood response and brain activity response to the stress task. Also our stress task included social 
evaluative threat- a type of stress that may be particularly relevant for mood in women (Kendler 
et al., 2001). Our data suggest that estradiol buffers the brain activity changes and negative mood 
response to psychosocial stress in normally cycling women. This work has important implication 
for an understanding of the relationship between estradiol levels and the response to stressful life 
events. Whether this has implications for the development of psychopathology remains to be 
studied. Future work should extend the investigation of ovarian hormone effects on psychosocial 
stress responding to women with vulnerability mood or anxiety disorders and further examine 
the relation of these effects to known risk factors for mood disorders.  
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Table 1: Participant Behavioral Measures at Screening 
 
E2 = Estradiol 
MDQ = Menstrual Distress Questionnaire (mean of most recent period and four days before)  
FFI = NEO Five Factory Personality Inventory  
BDI = Beck Depression Inventory 
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Table 2: Brain Activity during Psychosocial Stress  
Stress condition - control condition: All subjects (pooled across menstrual cycle, n = 28),  
cluster corrected uncorr p = 0.005, k =58 for p < 0.0001 
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Table 3: Menstrual Cycle/Estradiol Effect on Brain Activity during Psychosocial Stress 
 Stress condition - control condition: Low estradiol (n =10) – High estradiol (n =10), cluster corrected 
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Table 4: Distress Effect on Brain Activity during Psychosocial Stress.  
Stress condition - Control condition: Low distress (n = 14) – High distress (n = 14),  
cluster corrected uncorr p = 0.005 k = 58 for p < 0.001 
 















Table 5: Behavioral Measures at Study Day – Pre MIST 
 
E2 =Estradiol 
STAI = State and Trait Anxiety Inventory 








































Anxiety 29.3 7.54 29.80 7.13 0.88 29.07 6.40 28.64 7.60 0.87 
STAI - 
Trait 
Anxiety 34.6 10.55 33.10 7.40 0.71 33.64 10.10 30.43 6.27 0.32 
SACL -
Stress  1.90 2.88 2.20 4.32 0.86 2.57 4.13 0.64 1.08 0.10 
SACL -
Arousal  9.00 3.71 8.10 3.31 0.57 8.00 3.68 7.93 3.24 0.96 
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Table 6: Behavioral Measures at Study Day – Post MIST 
E2 =Estradiol 
STAI = State and Trait Anxiety Inventory 
SACL = Stress and Arousal Checklist 
POMS = Profile of Mood States 
STVAS = Stress Task Visual Analogue Scale 



































Figure 2: Psychosocial Stress Effect fMRI Stress Condition – Control Condition. All participants (n = 
28). Greater deactivation in limbic regions during the stress condition compared to the control condition 



















Figure 4: Estradiol Effects fMRI. 
Stress Condition – Control Condition: High estradiol (n = 10) – Low estradiol (n = 10). Greater 
activity in left hippocampus during the stress condition in the High estradiol group than the Low 





















Figure 5: Subjective Distress Effects fMRI. 
Stress Condition – Control Condition: Low Distress (n = 14) – High Distress (n = 14). Greater activity in 
bilateral hippocampus during the stress condition in the Low Distress group than the High Distress group 


































Figure 6: Cortisol fMRI. 
Stress Condition – Control Condition: All (pooled across menstrual phase, n = 28). Greater deactivation 






CHAPTER 3: ATTENTION BIAS IN REMITTED DEPRESSION IS ASSOCIATED 
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Cognitive bias is a common characteristic of major depression and is posited to remain 
during remission and contribute to recurrence risk. Attention bias may be related to enhanced 
amygdala activity or altered functional connectivity to amygdala and within attention networks 
in depression. The current study examined attention bias, brain activity for emotional images and 
functional connectivity in participants with and without a history of major depression. Attention 
bias for negative, positive, and neutral images in an emotion dot probe task during fMRI was 
examined in 33 postmenopausal women with (n = 12) and without (n = 21) a history of major 
depression. Additionally, group differences in functional connectivity to amygdala was assessed 
using a resting state MRI scan. There was a significant group difference for attention facilitation 
(t (31) = 2.83, p < 0.01) and amygdala activity (corr p < 0.001) during the emotion dot probe 
task. There were significant group differences in functional connectivity between the amygdala 
and hippocampal complex (corr p < 0.001). In all participants amygdala activity for negative 
images was positively correlated with attention facilitation for negative and positive trials. 
Additionally, amygdala activity and amygdala –hippocampal connectivity were positively 
correlated with attention facilitation for negative images. These findings provide evidence that 
differences in activity and functional connectivity in limbic and attentional networks may 







Cognitive bias for negative emotional information is a common characteristic of mood 
and anxiety disorders; depressed and dysthymic individuals show enhanced memory and 
attention (Sears et al., 2011; Wiens and Syrjänen, 2013; Isaac et al., 2014; Duque and Vázquez, 
2015) for negative information consistent with cognitive models of depression. Beck’s model 
(Beck, 2005; Beck and Haigh, 2014) posits that greater attention or memory for negative events 
contributes to the development, maintenance, and recurrence of depression by influencing 
schemas about the self and the world. A causative link between cognitive bias and mood is 
suggested by the finding that methods that modulate attention bias also affect anxiety and 
depressive symptoms (Hallion and Ruscio, 2011). Experimentally, cognitive bias modification 
has been shown to be able to both decrease depressive symptoms (by reducing negative bias) and 
increase depressive symptoms (by increasing negative bias), indicating that bias in attention may 
contribute directly to depressive symptoms rather than being a consequence of depressed mood.  
An important component of the cognitive model of depression is that cognitive bias is a 
trait marker of depression vulnerability and should remain in euthymic individuals with remitted 
depression (Sears et al., 2011). Mood congruent cognitive biases have been reliably found in 
currently depressed individuals and are associated with the severity of depressive symptoms and 
specific for depression-related information (Gaddy and Ingram, 2014). Cognitive biases in 
euthymic, remitted depressed individuals may indicate a trait cognitive vulnerability for 
depression (Joormann and Gotlib, 2007; Sears et al., 2011) that contributes to a high risk of 
recurrence (Kessler et al., 2003,Solomon et al., 1997; Keller and Berndt, 2002).  
Altered activity in fronto-limbic circuits has been associated with cognitive bias, negative 
mood, and rumination in currently depressed individuals. De Raedt and Koster (2010) posit a 
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model of depression vulnerability in which decreased dorsal prefrontal activity and increased 
stress-related amygdala activity contributes to negative mood and risk for future depressive 
episodes (Raedt and Koster, 2010). This model is supported by studies demonstrating that both 
currently depressed (Arnone et al., 2012), and at risk populations (Zhong et al., 2011) show 
greater amygdala activity to negative emotional stimuli than never depressed healthy controls. 
Attentional bias for negative information in remitted depressed individuals may be related to 
greater amygdala responses and enhanced attention to negative stimuli (Sears et al., 2011). 
Whether attentional bias in individuals with remitted depression is associated with parallel 
alterations in neural activity to emotional stimuli has not been previously examined. Brain 
activity or functional connectivity differences that remain in remission may represent a 
neurobiological basis for continued cognitive biases and vulnerability to depression.  
To assess attentional bias in euthymic individuals with remitted depression we examined 
performance and functional brain activity in participants with and without a history of depression 
during an emotion dot probe (EDP) task. We used fMRI during the EDP task and a resting scan 
before the task to examine task-related brain activity and functional connectivity differences 
between participants with and without a history of MDD. We hypothesized that participants with 
a history of MDD would show attentional bias for negative images that would not be seen in 
participants without a history of MDD, and that attentional bias would be associated with greater 








Thirty three right handed postmenopausal (Past MDD: n =12; No MDD: n = 21) women 
between the ages of 45-75 were included in this study. None of the participants were taking 
ovarian hormones and were at least one year without such treatment. Participants were recruited 
for a larger study examining the effects of estradiol replacement on stress responding in 
postmenopausal women with and without a history of depression, thus all participants in this 
study were postmenopausal women. No participants received estradiol treatment prior to or 
during participation in this study. This study was approved by the Vanderbilt University 
Institutional Review Board and informed consent was obtained from all participants. 
Cognitive Screening:  
  All participants were cognitively assessed using: the Wechsler Abbreviated Scale of 
Intelligence (WASI) (Wechsler, 1996), the Mini Mental State Exam (MMSE) (Folstein et al., 
1975), Brief Cognitive Rating Scale (Reisberg and Ferris, 1988), and the Mattis Dementia Rating 
Scale (Schmidt et al., 2005) to establish a Global Deterioration Scale score (GDS) (Reisberg et 
al., 1988). Participants were required to have a GDS score of 1-2 and a MMSE score of greater 
than 26. No participant scored below 123 on the Mattis scale or below 90 on the WASI; 
participants were of average or above intelligence with no evidence of dementia or mild 
cognitive impairment. 
MDD History Screening 
  Participants were screened for current and past depression, mania and dysthymia using 
the partial Structured Clinical Interview for DSM-IV-TR (SCID) (Spitzer et al., 1992). No 
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participants met criteria for a history of premenstrual dysphoric disorder on the Composite 
International Diagnostic Interview for premenstrual dysphoric disorder (CICI-PMDD).  
  Criteria for never depressed participants were: no current or past episodes that met SCID 
criteria for MDD, dysthymia, or mania, a current score less than 7 on the Beck Depression 
Inventory (BDI), and less than 15 on Beck Anxiety Inventory (BAI) (Beck et al., 1961). 
Criteria for prior history of MDD were: at least one episode, in the last ten years that met criteria 
for MDD on the SCID, no MDD episodes in the last year, current BDI score less than 7, and 
current BAI less than . 
Emotion Dot Probe (EDP) Task 
  The EDP task is a spatial attention task that measures attention facilitation (Kimonis et 
al., 2006). The EDP task used in this study was a picture variant using images from the 
International Affective Pictures System (Lang et al., 1999) and included neutral, positive, and 
negative images. Trials of the EDP consisted of a fixation cross presented in the middle of the 
screen, followed by a brief presentation (500 ms) of a picture pair with one image each on the 
right and left of the screen. After the picture presentation, a target (asterisk) appeared either on 
the right or left of the screen (replacing one of the images) and the participant was instructed to 
indicate by finger button press the side of the screen on which the target appeared as quickly as 
possible (available response duration was 1750ms). The time between the target’s appearance 
and the subject’s response was used for the calculations of reaction time; with incorrect trials 
excluded. 
The EDP was adapted for MRI and run as an event related design with three trial types 
relevant to the presented data: “Neutral” trials: neutral-neutral pair; “Negative” trials: neutral-
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negative pair; and “Positive” trials: neutral-positive image. There were no trials in which 
negative and positive images were presented together and the presentation order of trial types 
was randomized. In 2/3 of “Negative” or “Positive” trials the target replaced the emotionally 
valenced image. These trials were used for the measurement of attention facilitation. Attention 
facilitation for each emotional trial type was defined as the difference in reaction time between 
“Negative” or “Positive” trials and “Neutral” trials. A shorter reaction time for “Negative” or 
“Positive” trials indicated attention facilitation for negative or positive images. In 1/3 of 
“Negative” and “Positive” trials the target replaced the neutral image. These trials were used for 
the measurement of attentional preference (in other literature referred to as attentional bias). 
Attentional preferences was measured as the difference in reaction time for trials in which the 
target replaced the neutral image and trials in which the target replaced the emotionally valenced 
image. Only correct trials were included in performance measure calculations. ANOVAs were 
run for group differences in attention facilitation and preference for “Negative” and “Positive” 
trials. Independent t-tests were run for group differences in attention facilitation for “Negative” 
and “Positive” trials. 
Self-rated Measures 
Before the EDP, participants completed self-rated measures including: the State – Trait 
Anxiety Inventory (STAI) (Spielberger, 2010), the Stress Arousal Checklist (SACL) (King et al., 
1983), and the Profile of Mood States (POMS) (McNair et al., 1989). Following the EDP, 
participants completed a second SACL and POMS, and a visual analogue scale (VAS) for task 
perception including: the extent of their personal involvement, how stressful, new, 
uncontrollable, and unpredictable the task was, and whether they anticipated negative 
consequences. These measures have been previously used to assess the stressfulness of 
122 

laboratory tasks and procedures (Kirschbaum et al., 1999; Kudielka et al., 2004). Independent t-
tests were run for group differences in STAI, VAS, and for difference score on the SACL and 
POMS (pre to post EDP). 
Imaging Parameters 
Participants were scanned on a Philips 3.0 Tesla Achieva scanner, with an 8 channel head 
coil. All participants received the following MR sequences:  
1) Sagittal T1-weighted 3D Turbo Field Echo Sensitivity Encoding (TFE SENSE) sequence 
perpendicular to the anterior commissure (AC) -posterior commissure (PC) line, repetition time 
(TR) of 9.9 ms, echo time (TE) of 4.6 ms, a flip angle of 8°, number signal averages (NSA) 1.0, 
a field of view (FOV) of 256 mm, a 256 × 256 matrix, and 1.0 mm slice thickness with no gap 
for 140 contiguous slices.  
2) T2- weighted Gradient and Spin Echo (GRASE) sequence parallel to the AC-PC line, TR 
2470 ms, TE 80 ms, NSA 3.0, FOV of 230 mm, 0.7 mm slice thickness with 5.0 mm gap for 28 
slices 
3) Echoplanar Blood Oxygenation Level Dependent (EpiBOLD) functional resting-state scan 
with transverse orientation, TR 1500 ms, TE 35 ms, flip angle 90°, 1 NSA for FOV 240 mm, 
80X80 matrix, and 5.0 mm slice thickness with no gap, for 24 slices.  
4) EpiBOLD functional sequence during the EDP with transverse orientation, TR 2500 ms, TE 
35 ms, flip angle 90°, 1 NSA for, FOV 240, 240X128 matrix, and 4.0 mm slice thickness with no 





fMRI data was processed using Statistical Parametric Mapping (SPM8) (Wellcome 
Department of Cognitive Neurology, 2008). Preprocessing included: realignment of the 
functional runs and correction for bulk-head motion, coregistration of functional and anatomical 
images for each participant, segmentation of the anatomical image, normalization of the 
anatomical and functional images to the standard MNI template, and spatial smoothing with a 
Gaussian filter (8 mm at full width, half maximum).  
At first level analysis, T-maps were created from linear contrasts for the task conditions 
“Negative – Neutral” and “Positive – Neutral”; these T-maps were used in the whole-brain 
(masked for gray matter) second level random effects analysis of participant group effects with 
two-sample t-tests. The preprocessed functional images had a voxel size of 2X2X2 mm and 
cluster threshold correction was used to control for multiple comparisons (from voxel wise p = 
0.005) to corrected p < 0.001 with k = 58 (corrected voxel-wise p = 0.000001)from alpha 
simulation in REST (Song et al., 2011) toolbox for SPM. Average percent signal change (task 
condition – fixation time between trials) was calculated for each significant cluster from the 
second level group comparison using MARSBAR (Brett et al., 2002). 
Functional Connectivity Analysis 
Each participant completed a resting scan (eyes open with fixation cross) before the EDP 
task scan. Images from the resting scan were preprocessed in SPM8 including: realignment of 
the functional runs and correction for bulk-head motion, coregistration of functional and 
anatomical images for each participant, segmentation of the anatomical image, and normalization 
of the anatomical and functional images to the standard MNI template. To evaluate resting state 
124 

functional connectivity to amygdala, we entered right and left amygdala (anatomical ROI from 
the human AAL atlas defined in WFU PickAtlas) as seeds in a resting state functional 
connectivity analysis performed using the MATLAB-based functional connectivity toolbox 
CONN (Whitfield-Gabrieli and Nieto-Castanon, 2011). Each subject’s normalized structural and 
functional images and T1W tissue maps were used as input into CONN. The resulting BOLD 
time series were band-pass filtered (0.01-0.1Hz) to further reduce noise and increase sensitivity. 
The output matrices of SPM movement were entered into Conn as first-level covariates; the 
mean BOLD time series from each seed was entered as a predictor in a multiple regression 
general linear model at each voxel. 
Individual subject functional connectivity maps (in beta-weight units) were entered into a 
whole-brain (masked for gray matter) second level random effects analysis of participant group 
effects with two-sample t-tests. Cluster threshold correction was used to control for multiple 
comparisons (from voxel wise p = 0.005) to corrected p < 0.001 with k = 58 (corrected voxel-
wise p = 0.000001) (from alpha simulation in REST (Song et al., 2011) toolbox for SPM).  
Results 
Participants 
Participants in this study were 33 postmenopausal women. Twenty one women had no 
history of depression (MDD Hx-), and 12 had a past history of depression (MDD Hx+). 
Depression history was assessed using the SCID: time since first episode (M = 17.81 years, SD = 
10.85), number of episodes (M = 2.1, SD = 0.95), time since last episode (M = 4.1 years, SD = 
2.38). There was no significant difference in age between the participant groups (Table 1). All 
participants scored within the normal range for age on the DRS, WASI IQ, and MMSE, and no 
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participants endorsed significant impairments on the BCRS or GDS. There were no significant 
difference between groups on these measures nor on the NEO, BDI, or BAI (Table 1), 
additionally all participants scored within the non-clinical range on these measures consistent 
with a euthymic state. Two of the participants in the MDD HX+ group (and no participants in the 
MDD Hx-) were currently taking antidepressants during study participation. Participants taking 
antidepressant medication were required to have been on the same medication and dosage for at 
least 3 months. The effect of removing the 2 participants taking antidepressant medication from 
analysis was examined; all results remained significant and the direction of effects was not 
changed. 
Self-rated Measures 
There were no differences between participant groups on any of the subjective measures 
(Table 2). In an analysis including all participants, SACL arousal significantly decreased after 
the EDP compared to before the EDP (t (35) = 4.65, p < 0.001); there was no significant change 
in SACL stress (t (35) = -0.88, p = 0.38) or POMS total mood disturbance (p = 0.13). There was 
no significant difference between groups in the change in SACL arousal (t (34) = 0.52, p = 0.61), 
SACL stress (t (34) = 0.38, p = 0.71), or POMS total mood disturbance (t (34) = 0.80, p = 0.43) 
pre and post EDP. The EDP did not increase subjective stress or negative mood, and there was 
no difference between the MDD Hx+ and MDD Hx- groups in these self-rated measures. 
Emotion Dot Probe Performance 
There was a difference between groups in attention facilitation for negative images 
(reaction time “Neutral” trial – reaction time “Negative” trials) (F(1) = 5.40, p = 0.03); the MDD 
Hx+ group had similar reaction times for “Negative” trials compared to “Neutral” trials (M = -
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.30 ms, SD = 16.08), while the MDD Hx- group had faster reaction times during “Neutral” trials 
compared to “Negative” trials (M = 18.71 ms, SD = 13.65) (Figure 1).Thus the MDD Hx- group 
showed attention facilitation for neutral images, while the MDD Hx+ group did not.  
There was no difference in attention facilitation for positive images compared to neutral 
images between the groups (F (1) = 0.58, p = 0.45). Both groups had faster reaction times for 
“Neutral” trials compared to “Positive” trials: MDD Hx- (M = 18.70 ms, SD = 15.82) MDD Hx+ 
(M = 12.90, SD = 17.43).  
There was no difference between groups for attention preference for negative (F (1) = 
0.18, p = 0.68) or positive (F (1) = 0.00, p = 0.97). Further analysis and discussion will address 
attention facilitation only. In an analysis of reaction time for each trial type, the MDD HX+ 
group was slower for all trial types, however there was no significant differences in reaction time 
between groups for any trial types (negative trials: t(32) = -0.52, p = 0.61; positive trials; t(32) = 
-0.99, p = 0.33; neutral trials; t(32) = -0.99, p = 0.31). 
Task fMRI 
There was a difference between groups in brain activity during task trials which 
contained either negative or positive images (corrected p < 0.001) (Figure 1). The MDD Hx+ 
group had significantly greater activity in the left amygdala, right parahippocampal gyrus, and 
bilateral precuneus during negative image trials (“Negative”- “Neutral”) than the MDD HX- 
group (Figure 2). During positive image trials (“Positive”- “Neutral”), the MDD Hx+ group had 
greater activity in the left amygdala and bilateral precentral gyrus than the MDD Hx- group. 
There was no difference in activity during trials that contained only neutral images. 
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Left amygdala activity for negative images was positively correlated with attention 
facilitation for both negative and positive images in an analysis of all participants, with the 
correlation stronger for negative facilitation (negative facilitation: r = 0.44, p < 0.01, positive 
facilitation: r = 0.34, p < 0.05). However, there was no association between amygdala activity 
for positive images and attention facilitation for either negative or positive images. Activity in 
the right parahippocampus and bilateral precuneus was not significantly correlated with negative 
or positive facilitation. 
Functional Connectivity 
 Seeding right or left amygdala in a single t-test for all participants resulted in positive 
connectivity maps that include bilateral limbic regions (amygdala and hippocampus), temporal 
pole, inferior and superior temporal regions, basal ganglia, middle cingulum, insula, and inferior 
frontal regions. A second level independent t-test comparison of participants groups showed 
greater connectivity in the MDD Hx+ group between left amygdala and right 
parahippocampus/hippocampus and bilateral precuneus (corrected p < 0.001) (Figure 3). In an 
analysis of all participants, left amygdala resting connectivity to the right 
parahippocampus/hippocampus was correlated with negative facilitation (r = 0.36, p < 0.05) and 
amygdala activity during the EDP task (negative images: r = 0.47, p < 0.01; positive images; r = 
0.38, p < 0.05; neutral images: r = 0.47, p < 0.01). Left amygdala connectivity to precuneus did 
not significantly correlate with amygdala activity or performance during the EDP task. There 






Attention facilitation for negative images differed between the participant groups; 
participants with a history of MDD showed similar reaction times for negative and neutral trials, 
while participants without a history of MDD were faster to respond during neutral compared to 
negative trials. These findings suggest that participants without a history of MDD avoided 
orienting attention to negative images, while participants with a history of MDD showed 
attention bias or an inability to suppress preferential orienting to negative images.  
The difference in attention for negative images between the participant groups despite 
euthymic mood supports the hypothesis that cognitive bias is a trait characteristic of depression 
vulnerability rather than a consequence of negative mood. Beck’s cognitive model and recent 
studies in individuals with other risk factors for depression (Joormann and Gotlib, 2007; Zhong 
et al., 2012) suggest that cognitive biases may be present even before MDD onset and contribute 
to increased risk for mood and anxiety disorders. There were no group differences in attention 
preferences in this study, however previous studies indicate that attentional bias is modulated by 
psychosocial stress (Roelofs et al., 2007; Brüne et al., 2013; Sanchez et al., 2013). Stress 
proximal to EDP performance may reveal greater difference in attention bias between women 
with and without MDD history. Attentional bias for negative information that remains during 
depression remission may indicate a susceptibility to the depressogenic effects of negative events 
and stressors.  
In contrast to well accepted findings of bias for positive emotional information in never 
depressed individuals (Joormann and Gotlib, 2007; Sears et al., 2011; Sanchez et al., 2013; Isaac 
et al., 2014), this study found that both groups showed attention facilitation away from positive 
images. This study used shorter presentation durations and more complex visual stimuli than 
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previous studies that found positivity bias in never depressed participants. It may be that 
attentional avoidance of negative and positive images in never depressed participants represents 
an effect of arousal rather than valence. Both negative and positive images are higher in arousal 
ratings than neutral images in the IAPS. Additionally, because of the short stimuli presentation 
durations, participants may have adopted a strategy of avoiding highly arousing images in an 
attempt to avoid negative images. Electrophysiological studies have shown that voluntarily 
directing attention away from emotional distractors results in decreased amplitudes in signals 
that represents emotional attention (Cesarei et al., 2009; MacNamara and Hajcak, 2009) and 
affects reaction time especially for highly arousing images regardless of valence (Wiens and 
Syrjänen, 2013). Participants in the current study may have avoided directing attention to highly 
arousing images. However, participants with a history of MDD had equivalent reaction times 
during neutral and negative trials suggesting that they were less able to direct attention away 
from the negative images than from positive images. 
  Participants with a history of MDD also showed greater limbic and visual region activity 
for emotionally valenced images than participants without a history of MDD. In all participants 
left amygdala activity was correlated with attention facilitation for negative images, but not for 
positive images. These results suggest that there is a stronger relation between amygdala activity 
and attention for negative information than positive information. The amygdala has direct 
bidirectional projections to early visual areas and likely enhances attention to emotional 
information through feedback mechanisms to visual regions (Pourtois et al., 2013). Resting 
functional connectivity analyses in the current study indicated stronger connectivity between left 
amygdala and areas important for the integration of visual perception and attention (Cavanna and 
Trimble, 2006) in participants with a history of MDD. Attention networks in individuals with a 
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history of MDD may be predisposed to attentional gain for negative emotional information 
through amygdala feedback to visual regions.  
The results of this study should be interpreted with consideration to the limitations of the 
relatively small sample size for the MDD Hx+ group and the unbalanced sample size between 
the two groups. However the depression history of participants in this study was fairly 
homogenous with no participants having highly recurrent depressive episodes. Additionally, this 
study only included postmenopausal women as participants, which limits the interpretation of 
these results for young women and men. Although sex differences in attention bias in depression 
have not been previously examined, prior studies suggest sex differences in neural activity for 
emotional processing that may interact with gonadal hormone levels (Kret and De Gelder, 2012). 
Future studies should examine whether the association of depression history and cognitive bias 
differs by sex or hormonal status.  
Cognitive models predict that enhanced amygdala sensitivity and attentional processing 
of negative information increases depression risk by supporting negative cognitive schemas. 
Greater attention to negative information may contribute to the perception that negative 
information is more salient or predictive than neutral or positive information, and modulate the 
depressogenic effects of life events and stressors. The current findings of negative attention 
facilitation in correlation with amygdala activity and resting connectivity in attention networks 
provide evidence that differences in activity and functional connectivity in limbic and attentional 
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MDD Hx - (n = 21) MDD Hx + (n = 12) 

Mean Standard Deviation Mean Standard Deviation p value 
Age 60.64 6.81 62.42 5.79 0.45 
Dementia Rating Scale 141.45 2.52 137.00 14.32 0.16 
WASI IQ 118.10 10.17 115.55 12.36 0.54 
Global Deterioration Scale 1.73 .46 1.75 .45 0.89 
Brief Cognitive Rating Scale 9.36 1.14 9.83 1.34 0.29 
Mini Mental State Exam 29.09 1.06 29.58 .67 0.16 
NEO - Neuroticism 12.05 5.45 15.75 6.63 0.09 
NEO - Extraversion 32.82 3.97 31.75 6.63 0.56 
NEO - Openness 31.18 5.98 32.33 9.08 0.66 
NEO - Agreeableness 38.77 5.00 38.33 5.05 0.81 
NEO - Conscientiousness 36.32 5.57 35.33 8.21 0.68 
Beck Depression Inventory 2.91 3.21 2.17 2.62 0.50 














MDD Hx– (n = 21) MDD Hx+ (n = 12) 

Mean Standard Deviation Mean Standard Deviation p value 
Trait Anxiety 25.23 6.36 24.17 5.56 0.63 
State Anxiety 26.91 6.83 28.75 5.38 0.43 
Pre SACL - Stress 1.29 2.19 .83 1.34 0.45 
Pre SACL - Arousal 10.43 1.83 9.25 3.55 0.22 
Pre POMS - Total Mood Disturbance -13.14 13.10 -10.50 14.83 0.60 
Post SACL - Stress 1.95 3.91 1.08 1.51 0.47 
Post SACL - Arousal 7.36 3.76 6.67 3.58 0.60 
Post POMS - Total Mood Disturbance -9.32 17.10 -1.75 16.34 0.22 
VAS - Involved 81.68 22.70 83.42 14.72 0.81 
VAS - Stressful 19.77 22.16 22.42 25.17 0.75 
VAS - New 75.86 27.12 68.58 40.07 0.53 
VAS - Uncontrollable 26.41 33.00 23.92 23.02 0.82 
VAS - Unpredictable 52.00 33.82 40.08 29.06 0.31 












Figure 1- EDP Performance and Brain Activity: A) MDD HX- group (n=21) showed greater reaction 
time for both negative and positive images than neutral images during the EDP. The MDD Hx+ (n=12) 
group did not show a reaction time difference between negative and neutral images. The difference in 
reaction time between neutral and negative images was significantly greater in the MDD Hx- group 
compared to the MDD Hx+ group (t (34) =2.78, p < 0.01). B) Amygdala activity during the EDP was 
greater in the MDD HX+ during both negative positive images than the MDD Hx- group (corr p < 0.001). 














Figure 2- EDP Brain Activity 
Negative images - neutral images: MDD HX+ > -MDD HX- (corr p < 0.001). MDD Hx+ group 
had greater activity in the left amygdala and right hippocampal complex during negative images 

















Figure 3 - Functional Connectivity with Left Amygdala: 
Greater resting functional connectivity between left amygdala and right hippocampal complex and 




 CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS 
Review of Findings 
 The main findings of this dissertation provide information about the role of estradiol in 
the response to psychosocial stress, and amygdala activity and connectivity in attentional 
facilitation in women with remitted MDD. The findings of Chapter 2 demonstrate that estradiol 
levels in different menstrual phases modulate the neural and mood responses to psychosocial 
stress such that young women show greater hippocampal deactivation and negative mood to 
psychosocial stress during low estradiol phases of the menstrual cycle, while women in high 
estradiol phases appear to be protected against these effects of stress. Examining cognitive bias 
during MDD remission in Chapter 3 indicated that postmenopausal women with remitted MDD 
show enhanced amygdala activity for all emotional image types and attentional facilitation for 
negative images despite being euthymic. In both remitted and never depressed women amygdala 
activity for negative images was directly correlated with attention facilitation for negative and 
positive images. Resting functional connectivity analysis using the amygdala as a seed region 
demonstrated greater functional connectivity between the left amygdala and right hippocampal 
complex and visual regions in women with remitted MDD. Additionally, amygdala-hippocampal 
connectivity was directly correlated with both amygdala activity for all image types and attention 
facilitation for negative images. Data presented in Appendix A and discussed below indicate that 
amygdala-hippocampal functional connectivity was reduced following estradiol treatment only 
in women with remitted MDD and that estradiol treatment had interactive effects with MDD 
history on mood response to psychosocial stress such that women with remitted MDD benefitted 





The core symptoms of MDD represent dysfunction in systems that are necessary for 
maintaining euthymic mood and regulating endocrine and emotional responses to negative 
information and stress. One conceptualization of these systems is the dorsal and ventral divisions 
proposed by Phillips and others (Mayberg, 1997; Phillips et al., 2003, 2008; Price and Drevets, 
2012). The ventral system is comprised of brain regions including the amygdala that are involved 
in early and automatic information processing, which allows for the evaluation of emotional 
information and quick activation of autonomic and endocrine responses. The dorsal division 
includes the hippocampus and frontal regions that integrate current information with associations 
from memory and components of cognitive control (goal maintenance, decision making). These 
processes serve to place current information within the context of past experiences and future 
plans and regulate ventral activity. Gold’s model of stress response incorporates the dorsal and 
ventral divide and demonstrates the importance of maintaining a healthy balance between the 
systems for adaptive stress responding (Gold, 2015). 
 The hypothesis that dysregulated stress responding is integral to major depression is 
supported by consistent findings of endocrine abnormalities in MDD (Gold et al., 1986; Young 
et al., 1994, 2000) and the commonality of stressful life events as depression antecedents (Caspi 
et al., 2003; Kendler et al., 1999, 2000). Integrated brain systems for stress responding and 
emotional cognition provide a mechanism whereby enhanced ventral activity may result in 
altered cognitive schemas. Unregulated ventral activity results in suppressed function (Conrad et 
al., 1996; deQuervain et al., 1998; Diamond et al., 1999) and altered structural integrity 
(Magariños et al., 1996; Watanabe et al., 1992; Woolley et al., 1990) in dorsal regions and may 
thus perpetuate long-term enhanced emotional reactivity. Such an altered system may become 
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predisposed to ventral system processes and establish cognitive bias for negative emotional 
information, especially when efficient use of cognitive resources is necessary as during 
psychosocial stress. 
 During normal stress responding dorsal system activity is reduced and ventral activity is 
released from dorsal inhibition (Arnsten, 2009; Gold, 2015; Simpson et al., 2001). This shift in 
brain activity initiates autonomic and endocrine responses to the stressor and results in dysphoric 
mood (Gold, 2015; Phelps and LeDoux, 2005). The brain activity patterns in the presently 
reported study (Chapter 2) confirm that a similar shift in activity is seen during the stress 
condition of the MIST; activity is reduced in dorsal regions of the frontal and parietal cortex as 
well as hippocampus. These findings also replicate those of the task developers (Pruessner et al., 
2008), and confirm that a similar activation pattern is seen in young women as mixed-sex 
studies. 
  The findings reported in this dissertation support a role for estrogen in maintaining dorsal 
function during psychosocial stress in young women. Around ovulation, when estradiol levels 
are high, hippocampal activity was greater during psychosocial stress than in the early follicular 
phase when estradiol levels are low. These results accord with estrogen’s known effects on 
hippocampal function and support of hippocampally-mediated cognition. Reduced hippocampal 
activity during stress in the low estradiol phase may suggests that normal fluctuations in ovarian 
hormones across the menstrual cycle establish states when the dorsal system exerts less control 
over ventral activity. During these phases women may be more susceptible to the depressogenic 
effects of stressful events. Indeed, in the presented study, negative mood or “distress” was 
greater following the MIST in women during the low estradiol phase and was related to both low 
estradiol and hippocampal deactivation during the stress condition. Similar to Phillips model, 
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Pruessner and colleagues posit that hippocampal activity towards evaluation of threat stimuli and 
automatic regulation of ventral activity is a default and ongoing function (Dedovic et al., 2009; 
Pruessner et al., 2008). Deactivation of the hippocampus releases ventral activity during the 
stress response and allows for activation of endocrine and autonomic responses (Dedovic et al., 
2009; Jacobson and Sapolsky, 1991; Sapolsky et al., 1984). The hippocampus may act as a 
gatekeeper for stress responding such that ventral activity must exceed a threshold to reduce 
hippocampal activity and activate subsequent stress response pathways. 
In healthy women the effects of estrogen on hippocampal regulation of stress responding 
may be subtle and acute, however for women with additional vulnerabilities or preexisting 
ventral-dorsal dysregulation, loss of estrogen support of dorsal function may contribute to the 
risk for depression following stressful events. A recent study examining the effect of emergency 
contraception following sexual assault found that six months after the assault women who 
received contraception that contained estradiol had less post-traumatic stress symptoms than 
women who received either contraception containing both estradiol and progesterone or no 
contraception (Ferree et al., 2012). These findings support the hypothesis that estradiol levels 
proximal to traumatic or stressful events may impact long term mood and memory for the event. 
The presented findings similarly demonstrate that high estradiol reduces the negative mood 
response following stressful events, likely through supporting hippocampal function and 
restraining ventral system involvement.  
 The study presented in Chapter 2 did not include women with current or past mood 
disorder. However preliminary data from a recent study (Appendix A) indicates that stress 
responsivity and estrogen effects may differ by depression history. Postmenopausal women with 
a past history of MDD had more negative mood or “distress” following the MIST than women 
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with no history of MDD (Appendix A). However, 3 months of estradiol treatment appears to 
reverse the effect of MDD history on mood response, such that estradiol treatment combined 
with a history of MDD was associated with a less negative mood response to the MIST than 
estradiol treatment in women without past MDD. Interestingly, in women with no history of 
MDD estradiol treatment was associated with a more negative mood response to the MIST. 
While this is the opposite effect as seen in young women (Chapter 2), this result agrees with 
previous findings in older women. Newhouse and colleagues previously found that estrogen 
treatment was associated with higher negative mood scores on the POMS following the Trier 
stress task in healthy postmenopausal women (Newhouse et al., 2008). Although the Trier task 
shares stressful components with the MIST (performance and social evaluative threat), it is not 
conducted in the MRI environment suggesting that estrogen has a general effect on the 
psychosocial stress response that is not specific to the type of stressor or the imaging 
environment.  
 The study presented in Chapter 2 and previous work in young women (Andreano and 
Cahill, 2010; Davydov et al., 2005; Goldstein et al., 2005) demonstrate that estrogen has 
beneficial effects on emotional processing and mood, however there may be a shift in these 
effects at menopause or with age such that estrogen has no or negative effect on mood following 
stress. Enhanced negative emotional response to psychosocial stress in euthymic women with a 
history of MDD may indicate ongoing vulnerability to depressive symptoms even during 
remission. However, depression history appears to alter the effects of estrogen, such that women 
who are vulnerable to depression may remain sensitive to the beneficial effect of estrogen 
following menopause.  
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For many MDD is a recurrent disorder. Cognitive models of MDD point to high 
recurrence rates as an indication that cognitive alterations remain during remission and confer 
continued vulnerability for depressive episodes (Beck, 2005; Hasselbalch et al., 2011). Bias in 
allocating cognitive resources such as attention and memory towards negative information may 
result in negative information appearing more salient than neutral or positive information thus 
reinforcing negative schemas. The findings in Chapter 3 demonstrate that euthymic 
postmenopausal women with remitted MDD show both greater amygdala activity and attention 
to negative information than women with no history of MDD.  
Women with no MDD history showed attentional facilitation for neutral images in 
contrast to previous findings in free viewing tasks that healthy individuals generally show 
attention bias for positive information(Cotton et al., 2015; Isaac et al., 2014; Joormann and 
Gotlib, 2007; Sanchez et al., 2013; Sears et al., 2011). Because of the limited image presentation 
duration, the EDP task simulates a situation in which processing and evaluation of emotional 
information must occur rapidly. Under these conditions women with no history of MDD appear 
to avoid attentional allocation to highly arousing information, thereby avoiding attending to all 
emotionally valenced images compared to neutral images.  
Performance on the EDP task suggests that women with past MDD show similar 
avoidance of positive images as women without such history, attend more to negative images but 
show no difference in attention between negative and neutral images. It may be that women with 
a history of MDD are not able to avoid attending to negative information, or alternatively, that 
they perceive neutral images as negative (as has been found in MDD (Gollan et al., 2008; 
Leppänen et al., 2004) ) and thus attend equivocally to negative and neutral images. Greater 
amygdala activity for all image types during the EDP in women with MDD history than without 
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such history suggests that automatic ventral system processing of emotional information differs 
between these groups even during remission and euthymia. In addition, amygdala activity was 
positively correlated with attentional facilitation on the EDP indicating that altered ventral-dorsal 
function and interactions has consequences for cognitive processes and bias that remains despite 
remission.  
The study presented in Chapter 3 found that amygdala-hippocampal functional 
connectivity was greater in women with past MDD than in women with no history of MDD and 
was correlated with attentional bias for negative images. The functional significance of increased 
amygdala-hippocampal resting connectivity is unclear; better correlated amygdala and 
hippocampal activity in women with past MDD may represent greater amygdala involvement in 
hippocampal activity. If this is the case one may expect greater connectivity to be related to 
better memory for negative information, which was not evident in the preliminary data 
(Appendix A). Alternatively, greater amygdala-hippocampal resting connectivity may indicate 
compensatory hippocampal control of enhanced amygdala activity in MDD. Amygdala activity 
during emotional images and amygdala connectivity to attention and visual processing areas 
were greater in women with MDD history (Chapter 3) suggesting that attentional bias for 
negative images may be related to enhanced amygdala activity and ventral-driven gain in 
attention and visual processes. The women in the current study were euthymic and remitted from 
MDD but still showed greater amygdala activity for emotional images and greater amygdala-
hippocampal functional connectivity than women with no history of MDD; remission from MDD 
may thus be accompanied by increased hippocampal regulation of amygdala activity. This 
hypothesis accords with previous studies which have shown that amygdala-hippocampal 
connectivity in healthy individuals is inversely correlated with cortisol response during 
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psychosocial stress (Vaisvaser et al., 2013) and with faster recovery from experimental HPA axis 
disruption (Kiem et al., 2013). Although greater amygdala-hippocampal functional connectivity 
may be associated with MDD remission, tasks such as the EDP may drive amygdala activity 
such that hippocampal regulation is overcome as indicated by greater amygdala activity in 
women with remitted MDD and related attentional bias. 
 Preliminary results presented in Appendix A demonstrate that 3 months of estradiol 
treatment reduced amygdala-hippocampal functional connectivity specifically in women with 
MDD history such that there was no significant difference in connectivity between women with 
and without a history of MDD following treatment. Whether the effect of estrogen on functional 
connectivity is accompanied by changes in cognitive bias was not investigated in this 
dissertation. However, the presented positive effect of estrogen on mood response to 
psychosocial stress in women with a history of MDD in combination with reduced amygdala-
hippocampal connectivity may indicate that estrogen normalizes ventral activity and reduces 
negative mood. 
MDD vulnerability appears to involve aberrant interactions between ventral affective 
processing pathways and dorsal regulatory and cognitive association pathways. Enhanced ventral 
activity or reduced dorsal regulation may result in altered cognitive processing of emotional 
information that biases attention and memory for negative information. The findings of the 
studies included in this dissertation suggest a role for estrogen in modulating emotional 
processing networks with effects on mood following psychosocial stress and cognitive 
processing of emotional information and support the integration of neural system dysregulation 
and cognitive models of MDD in women. 
151 

Ovarian hormones have long been proposed to have a role in the sex difference in MDD, 
however the mechanisms through which ovarian hormones affect depression vulnerability have 
been unclear. The study presented in Appendix A suggests that estrogen enhances dorsal system 
function and differentially modulates mood responses to psychosocial stress in postmenopausal 
women with and without a history of MDD. Similarly, Chapter 2 demonstrates that in healthy 
young women, estrogen fluctuations across the menstrual cycle affect the reduction in dorsal 
activity that characterizes the central stress response. The effect of low estrogen on the mood 
response to stress may be related to the negative mood commonly experienced prior to 
menstruation and create periods of increased risk for depressive symptoms in vulnerable women. 
Enhanced ventral activity is a common component in stress response dysregulation 
(Gold, 2015) and dorsal-ventral dysregulation models of MDD (Phillips et al., 2003; Price and 
Drevets, 2012) and has a central role in cognitive models as a driver of aberrant allocation of 
attention and memory for negative information (Beck, 2005; Pourtois et al., 2013). The relation 
between amygdala activity and attention bias for negative images found in Chapter 3 leads to the 
hypothesis that enhanced automatic ventral processing of negative emotional information may be 
a risk for MDD or recurrence. The findings presented in Chapter 3 indicate that amygdala-
hippocampal functional integration is stronger in women with past depressive episodes. 
However, it is unclear whether this enhanced functional connectivity represents aberrant 
amygdala involvement in hippocampal function that remains in remission and may drive 
cognitive bias towards negative information, or whether it indicates a compensatory mechanism 





Limitations and Future Directions 
 The results of this dissertation should be interpreted with consideration of a number of 
limitations. While all participants scored in the non-clinical range for mood symptoms at the 
study visit, the sample sizes precluded examination of factors that may affect the findings 
presented in Chapter 3 and the Appendix A, such as current depressive symptoms, number of 
depressive episodes, length of illness, and treatment history. However, participants in Chapter 3 
with past MDD represented a fairly homogenous MDD history with no highly recurrent or 
treatment resistant depressive episodes. None of the participants reported history of anxiety 
disorder and there were no group differences in trait or state anxiety, however because of the 
high comorbidity of depression and anxiety disorders further characterization of anxiety 
symptoms and history may be useful in determining the separate effects of depression and 
anxiety. The results presented in the Appendix A should be interpreted as preliminary findings as 
the group sizes were unbalanced and it is therefore difficult to ascertain the significance of 
findings concerning all participant groups.  
 Future work should examine the interactions between estrogen and mood disorder in 
young women and include participants with current illness to determine whether the beneficial 
effect of estrogen on mood response to psychosocial stress seen in older women with MDD 
history extends of young women and active mood disorder. The investigation of young women 
presented in this dissertation was designed to minimize the effects of progesterone, however 
pharmacological manipulation of ovarian hormones in young women may be useful in further 
characterizing the separate effects of estrogen and progesterone.  
This dissertation did not investigate the roles of neurotransmitter systems in stress 
responding or emotional processing and thus cannot provide information about these potential 
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mechanisms of estrogen’s effects. However, the findings support hippocampal function as a 
promising target of further investigation. Examining neurotransmitter systems that impact 
hippocampal function (such as the cholinergic system) may be of particular interest in future 
studies of estrogen’s effect on mood, stress response, and attention in relation to MDD. Similarly 
the effects of estrogen on cognitive bias should be further examined; the present study (Chapter 3 
and Appendix A) did not investigate attentional bias following estradiol treatment and found no 
evidence of memory bias, but did find an estradiol effect on amygdala-hippocampal functional 
connectivity which suggest that estrogen may alter the functional relationship between brain 
regions involved in cognitive processing of emotional information. Further, the addition of eye 
tracking during the EDP task may aide in distinguishing between attentional facilitation and 
avoidance.  
Conclusions 
The findings presented in this dissertation suggest that fluctuations of estrogen across the 
menstrual cycle and at other reproductive events may contribute to negative mood alterations 
through effects on brain systems integral to emotional evaluation and response with potential 
cognitive consequences. Estrogen may thus protect against the depressogenic effects of stressful 
life events in women. For women with current or past MDD, estrogen supplementation in young 
women or replacement in older women may be a successful strategy for preventing recurrence 
following stressful events. The association between negative mood response to psychosocial 
stress and ovarian hormone fluctuation in women supports stronger consideration of MDD in 
women as a reproductive phase-associated mood disorder and of hormone therapy as an 
adjunctive treatment similar to the standard ovarian hormone therapy treatment of premenstrual 
dysphoric disorder, post-partum depression, and polycystic ovarian syndrome. The findings in 
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this dissertation indicate that cognitive bias for negative information remains during remission in 
women and that estrogen affects brain networks involved in the cognitive processing of such 
emotional information.  
This work should be expanded to investigate the effects of menstrual cycle phase and 
estradiol level on psychosocial stress response in women who are currently experiencing 
depressive episodes or other mood and anxiety disorders such as post-traumatic stress disorder. 
Additionally, whether estradiol treatment or menstrual phase affects attention facilitation for 
negative images in women with current or past mood disorder should be examined. Determining 
the efficacy of cognitive bias modification in reducing depressive symptoms and perhaps 
reducing recurrence risk requires further investigation. However, ovarian hormone therapy may 
be a potential augmentative strategy in women by supporting new learning and modulate ventral-
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  Two groups of postmenopausal women were recruited, with and without a personal 
history of MDD. Of each MDD history group a portion of women received three months of 
open-label estradiol (E2) and a portion received no treatment. Mood response to psychosocial 
stress was assessed during a laboratory psychosocial stress task. We hypothesized that E2 
treatment would be associated with less negative mood response to the stress task only in women 
with a previous history of MDD. Recognition memory for emotionally-valenced words was 
tested after the stress task. We hypothesized that E2 treatment would decrease recognition 
memory for negative words following the stress task. Women who received E2 treatment 
completed both a baseline visit before treatment and a study day visit following treatment. The 
effects of E2 treatment on amygdala-hippocampal functional connectivity was analyzed using 
resting state scans from the baseline and study day visits. We hypothesized that E2 treatment 
would reduce amygdala-hippocampal connectivity specifically in women with MDD history 
(Figure 1). 
Participants 
Fifty three postmenopausal women between the ages of 45-75 were enrolled in this study. 
None of the participants were taking ovarian hormones and were at least one year without such 
treatment. Participants were recruited through mass mailing letters, fliers at clinical offices, 
Research Match, and email announcements to Vanderbilt faculty and staff. This study was 
approved by the Vanderbilt University Institutional Review Board and informed consent was 
obtained from all participants. 
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Participants were assigned to open-label oral E2 for 3 months (1mg per day for the first 
month, and 2mg per day for the second and third months) or to no treatment. Generally, women 
who were willing and medically able to take estradiol were placed in the E2+ group, while 
women who were not willing or had medical contraindications to estradiol were placed in the 
E2- group. One participant’s data was excluded from analysis as an outlier in MRI signal change, 
so that a total of 52 participants’ data are included in the data reported here. There were four 
participant groups: 1) women who received estradiol treatment with no history of MDD 
(E2+/MDD Hx- , n = 17;  2) women who received estradiol treatment with a history of MDD 
(E2+/MDD Hx+, n = 10); 3) women who did not receive estradiol treatment with no history of 
MDD (E2-/MDD Hx-, n = 20); 4) women who did not receive estradiol treatment with a history 
of MDD (E2-/MDD Hx+, n = 5). 
Cognitive Screening 
  All participants were cognitively assessed using: the Wechsler Abbreviated Scale of 
Intelligence (WASI) (Wechsler, 1996), the Mini Mental State Exam (MMSE) (Folstein et al., 
1975), Brief Cognitive Rating Scale (Reisberg and Ferris, 1988), and the Mattis Dementia Rating 
Scale (Schmidt et al., 2005) to establish a Global Deterioration Scale score (GDS) (Reisberg et 
al., 1988). Participants were required to have a GDS score of 1-2 and a MMSE score of greater 
than 26. No participant scored below 123 on the Mattis scale or below 90 on the WASI; 






MDD History Screening 
  Participants were screened for current and past depression, mania and dysthymia using 
the partial Structured Clinical Interview for DSM-IV-TR (SCID) (Spitzer et al., 1992). No 
participants met criteria for a history of premenstrual dysphoric disorder on the Composite 
International Diagnostic Interview for premenstrual dysphoric disorder (CICI-PMDD).  
  Criteria for never depressed participants were: no current or past episodes that met SCID 
criteria for MDD, dysthymia, or mania, a current score less than 7 on the Beck Depression 
Inventory (BDI), and a score less than 15 on Beck Anxiety Inventory (BAI) (Beck et al., 1961). 
  Criteria for prior history of MDD were: at least one episode, in the last ten years that met 
criteria for MDD on the SCID, no MDD episodes in the last year, current BDI score less than 7, 
and current BAI less than 15 (Santesso et al., 2008).  
Participants in the estradiol treatment group completed an additional study day prior to 
estradiol treatment, the results of that baseline day are presented in Chapter 3, however resting 
functional connectivity comparison between the baseline and study day for the estradiol 
treatment group will be presented below. 
Stress Task 
 We employed the Montreal Imaging Stress Task (MIST) for psychosocial stress 
induction (Pruessner et al., 2008). The MIST produces moderate psychosocial stress through a 
combination of motivated performance and social-evaluative threat. We presented the MIST as 
an arithmetic task in the MRI scanner, and instructed participants that they should achieve an 80-
90% correct performance for their data to be usable in the context of this experiment. 
Unbeknownst to the subjects, the MIST contains an algorithm producing script that 
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automatically adjusts the difficulty of the math tasks to the aptitude of the participant, this way 
maintaining a low performance rate (between 40-50%) by changing either the problem difficulty 
or the allotted time. A “control” condition, in which the participants solve arithmetic problems 
with no time limit and no performance limit, serves as a contrast to control for brain activity 
changes induced by arithmetic task demands (visual stimuli, motor response, and mental 
arithmetic). Social evaluative threat comes from scripted experimenter interaction; the 
experimenters enter the MRI room between runs and inform the participants that they are not 
doing well enough and that they need to improve their performance for the experiment to be 
successful.  
In this study, participants completed three runs of the MIST. After the first run, 
experimenter 1 entered the scanner room and provided the scripted feedback and asked the 
participant to complete a second run of the task. After the second run the experimenter 1 entered 
the scanner room and told the participant that the experimenter 2 (“doctor”) would like to speak 
with them about their performance, at which point the experimenter 2 entered the scanner room 
and provided the scripted feedback and asked the participant to complete a third run of the task. 
This protocol was designed to maintain both performance and social evaluative threat throughout 
the MIST and to prevent participants from habituating to the performance challenge or giving up 
on completing the task. Specifically the interaction of the participants and the experimenters was 
structured to generate psychosocial stress. To habituate the participants to the scanning 
environment and decrease scanner-related stress at the study day, participants entered an MRI 
simulator during the screening visit; in the MRI simulator, participants watched a nature video 
while being exposed to the MRI environment (simulated MRI sounds, head coil, and being 
placed in the MRI bore) and the stimulus presentation system.  
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The MIST was presented in a block design; each condition was presented twice per 3 
runs (“stress”: 100 seconds, “control”: 50 seconds, “rest”: 30 seconds). Participants practiced the 
MIST task (control trials only) in the MRI simulator, before the MRI session.  
Imaging Parameters 
  Participants were scanned on a Philips 3.0 Tesla Achieva scanner, with an 8 channel head 
coil. All participants received the following MR sequences:  
1) Sagittal T1-weighted 3D Turbo Field Echo Sensitivity Encoding (TFE SENSE) sequence 
perpendicular to the anterior commissure (AC) -posterior commissure (PC) line, repetition time 
(TR) of 9.9 ms, echo time (TE) of 4.6 ms, a flip angle of 8°, number signal averages (NSA) 1.0, 
a field of view (FOV) of 256 mm, a 256 × 256 matrix, and 1.0 mm slice thickness with no gap 
for 140 contiguous slices.  
2) T2- weighted Gradient and Spin Echo (GRASE) sequence parallel to the AC-PC line, TR 
2470 ms, TE 80 ms, NSA 3.0, FOV of 230 mm, 0.7 mm slice thickness with 5.0 mm gap for 28 
slices 
3) Echoplanar Blood Oxygenation Level Dependent (EpiBOLD) functional resting-state scan 
with transverse orientation, TR 1500 ms, TE 35 ms, flip angle 90°, 1 NSA for FOV 240 mm, 
80X80 matrix, and 5.0 mm slice thickness with no gap, for 24 slices.  
4) Three EpiBOLD functional sequences during the 3 runs of the MIST with transverse 
orientation, TR 2500 ms, TE 35 ms, flip angle 90°, 1 NSA for, FOV 240, 240X128 matrix, and 
4.0 mm slice thickness with no gap, with ascending interleaved acquisition, for 35 contiguous 
slices (task-related fMRI data will not be presented). 
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Functional Connectivity Analysis 
Participants who received estradiol treatment completed resting scans (eyes open with 
fixation point) before task scans during the MRI session at both the baseline (pre estradiol) and 
study day (post estradiol). Images from the resting scan were preprocessed in SPM8 including: 
realignment of the functional runs and correction for bulk-head motion, coregistration of 
functional and anatomical images for each participant, segmentation of the anatomical image, 
and normalization of the anatomical and functional images to the standard MNI template.  
Each subject’s normalized structural and functional images and T1W tissue maps were 
used as input into CONN. The resulting BOLD time series were band-pass filtered (0.01-0.1Hz) 
to further reduce noise and increase sensitivity. The output matrices of SPM movement were 
entered into Conn as first-level covariates; the mean BOLD time series from each region-of-
interest was entered as a predictor in a multiple regression general linear model at each voxel.  
To evaluate whether estradiol treatment affected the difference in amygdala-hippocampal 
functional connectivity between MDD history groups (presented in Chapter 3) a mask created 
from the significant hippocampal cluster in Chapter 3 was used as an ROI in a 2nd level resting 
state functional connectivity analysis with the left amygdala as a seed region (anatomical ROI 
from the human AAL atlas defined in WFU PickAtlas42). Cluster threshold correction was used 
to control for multiple comparisons within the hippocampal ROI (from voxel wise p = 0.05) to 
corrected p < 0.001 with k = 7 (corrected voxel-wise p < 0.001) (from alpha simulation in REST 
toolbox for SPM (Song et al., 2011)). Independent t tests were run to compare mean correlations 
between activity time series in the left amygdala seed and right hippocampal ROI between 





  Before the MIST, participants completed self-rated measures including: the State – Trait 
Anxiety Inventory (STAI) (Spielberger, 2010), the Stress Arousal Checklist (SACL) (King et al., 
1983), and the Profile of Mood States (POMS) (McNair et al., 1989). Following the EDP, 
participants completed a second SACL and POMS, and a visual analogue scale (VAS) for task 
perception including: the extent of their personal involvement, how stressful, new, 
uncontrollable, and unpredictable the task was, and whether they anticipated negative 
consequences. These measures have been previously used to assess the stressfulness of 
laboratory tasks and procedures (Kirschbaum et al., 1999; Kudielka et al., 2004). A 2X2 (E2 
treatment X MDD Hx) multivariate ANOVA, with alpha = 0.05 was run for all self-rated 
measures, and for difference score on the SACL and POMS (pre to post MIST). Change in 
SACL-Stress score was termed “Distress” for analysis. Independent T test with alpha = 0.05 
were run for groups comparisons for measures that had significant effects of the interactions E2 
X MDD Hx. 
Emotional Words Memory Task 
At the study day participants completed an emotional episodic memory task that 
consisted of an encoding (before the MIST) and recognition phase (after the MIST). During the 
encoding phase, subjects were presented with 30 words for study (10 neutral, 10 positive, and 10 
negative). The study words were taken from the Affective Norms for English Words (ANEW) 
list (Bradley and Lang, 1999), which provides a set of normative emotional ratings, including 
valence and arousal, for a large number of words in the English language. Words used were of 
medium frequency of occurrence, and high concreteness. During the encoding task, subjects 
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were instructed to read the words out loud, to ensure that they read each word, and to try to 
remember the words for later testing.  
  During the recognition phase, subjects were presented with a combination of the 30 
words that were presented during the encoding phase, and 30 new words that were not presented 
during the encoding task. Subjects were instructed to press a button to indicate whether the word 
was an old word that they had seen previously or a new word they had not seen prior to the fMRI 
session. The new words were matched on valence, frequency, and concreteness to the studied 
words. Measures of sensitivity and response bias were obtained from the behavioral performance 
of this task. Performance on the emotional memory task was calculated by d’, a measure of 
sensitivity in detecting hits and false alarms, response bias was calculated as C, a measure of bias 
to respond to a binary choice either towards “yes” (liberal bias) or “no” (conservative bias). 
Similar protocols have been used to study that effects of cortisol administration and acute 
laboratory stress on emotional memory encoding and consolidation (Buchanan and Lovallo, 




Functional Connectivity  
 A resting functional connectivity analysis for the left amygdala seed with the 
hippocampal ROI created from the significant cluster in the results of Chapter 3 was completed 
only for participants who received estradiol treatment and thus had both a baseline pre estradiol 
treatment resting scan and a study day post estradiol treatment resting scan. Comparison of 
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functional connectivity at the baseline visit showed greater connectivity between the left 
amygdala and right hippocampus in the MDD Hx+ group compared to the MDD Hx- group 
 ( t(26) = 4.68 , p < 0.01), confirming the results in Chapter 3 in this subset of participants. There 
was no significant difference in left amygdala-right hippocampal functional connectivity 
between MDD Hx+ group and MDD HX-group at the study day following estradiol treatment (t 
(26) = -0.26, p = 0.80). Comparison of change in functional connectivity between left amygdala 
and right hippocampus (estradiol effect) showed a significant difference between groups (t (26) = 
2.50, p = 0.02). Paired t test showed that the MDD Hx+ group had a significant decrease in left 
amygdala right hippocampal function connectivity from baseline to study day (t(10) = 3.09, p = 
0.01), while the MDD Hx- group had no significant change (t(16) = -0.50, p = 0.62). 
Subjective Measures 
  In a 2X2 (E2 treatment X MDD Hx) multivariate ANOVA, there was a main effect of E2 
treatment for a number of pre MIST measures with the E2+ groups having significantly lower 
scores : STAI – state, BDI, BAI, Pre POMS-Depression (Table 1). There was an effect of the 
interaction E2 X MDD Hx for VAS- Unpredictable (F (1) = 8.45, p = 0.01) and change in 
SACL-Stress “Distress” (F (1) = 8.00, p = 0.01). In independent T-tests for group comparisons 
there was a trend (t (25) = 1.37, p = 0.06) for greater VAS-Unpredictable score in the 
E2+/MDD+ group (M = 85.80, SD = 19.22) compared to the E2+/MDD Hx- group (M = 65.12, 
SD = 30.10); there were no significant differences in VAS-unpredictable for all other group 
comparisons. There was a significant difference in “distress” in the group comparisons: 1) The 
E2+/ MDD Hx- group had greater (t(25) = 2.80, p = 0.01) “distress” than the E2+/MDD Hx+ 
group; 2) The E2+/MDD Hx- group also had greater (t(35) = 2.15, p = 0.04) “distress” than the 
E2-/MDD Hx- group; 3) The E2-/MDD Hx –  group had greater (t(35) = -1.47, p = 0.16) 
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“distress” than the E2-/MDD Hx+ group (Table 2). In women who did not receive estradiol, 
women with MDD history had a more negative mood response to the MIST than women without 
MDD history. However, in women who received estradiol treatment this was reversed; women 
with MDD history had a less negative mood response than women without MDD history. 
Emotional Words Memory Task 
 In a 2X2 (E2 treatment X MDD Hx) ANOVA of emotional words memory task 
performance there were no main effects of E2 or MDD history, and no significant interaction 
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Figure 1: Study Overview 
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